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Abstract  
  Rapamycin, a putative anti-aging drug, has been shown to extend the lifespan of several model 
organisms. Rapamycin’s core effect is to inhibit a major nutrient sensing pathway of the cell, 
mechanistic Target of Rapamycin Complex 1 (mTORC1). This inhibition was previously thought to induce 
similar beneficial effects that parallel caloric restriction – the restriction of calories in an organism 
without causing malnutrition. Previous work has shown that Rapamycin induces significant changes in 
gene expression of normal human dermal fibroblasts, as well as inducing repositioning of chromosome 
within the nuclear volume. However, questions remained on how other chromosomes repositioned and 
if changes were occurring at sub-chromosomal levels. By utilizing fluorescence in situ hybridization 
(FISH) and Chromosome Conformation Capture (3C), we analyzed genome organization under several 
different growth conditions including Rapamycin treatment. Despite significantly altering the transcript 
levels of several CXCL (chemokine C-X-C motif ligand) genes during treatment with Rapamycin, we 
observed only minimal movement of chromosome 4 which contains these genes. However, when we 
analyzed the sub-chromosomal organization of the locus containing these genes, we discovered altered 
topology in response to both Rapamycin treatment and reversible growth arrest through induction of 
quiescence. We also observed that interactions occurred between LIF (Leukemia inhibitory factor) and 
two putative enhancers. Furthermore, we investigated a locus containing several KRTAP (keratin 
associated proteins) on chromosome 17 and discovered they also altered local genome topology in 
response to our treatments.  
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1.0 Review of the Literature 
1.1 Introduction 
  Organization of the genome is fundamental for living organisms. The nucleus is a highly 
organized environment where chromosomes occupy defined volumes, known as chromosome 
territories (CT). Additionally, organization occurs below sub-chromosomal levels and play roles in the 
regulation of nuclear processes such as replication, repair and transcription. This folding of the genome 
has implications in many cellular processes, such as ageing and differentiation. However, it is unknown 
how somatic cells respond to external stimuli to refold their genome (or even if this is required) to 
facilitate the expression or repression of the appropriate genes. The drug Rapamycin disrupts cellular 
nutrient sensing and has been ascribed as an anti-ageing drug, with treatment in several model 
organisms resulting in increased lifespan (Bjedov et al., 2010; Ehninger et al., 2014; Harrison et al., 
2009). We hypothesize that treating cultured primary dermal fibroblasts with Rapamycin will be 
informative on nutrient response and the ageing process. This project has several focuses based around 
genome organization, including: analysis of chromosome territory reorganization by fluorescence in situ 
hybridization (FISH), and analysis of long-range chromatin interactions using Chromosome Conformation 
Capture (3C). As 3C is a new technique we will be identifying internal controls and optimizing the 
protocol. The protocol will then be used for the analysis of genomic interactions within a region of 
chromosome 4 based on previous finding from RNA-Sequencing (RNA-Seq) data.  
 
1.2 mTOR and Rapamycin 
 The mechanistic Target of Rapamycin (mTOR) pathway, named after its inhibitor Rapamycin, 
functions as a centralized nutrient sensing hub. mTOR is responsible for transducing up-stream 
nutritional signals to downstream effectors through multiple protein pathways and has a significant role 
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in many functions. The mTOR pathway guides cell growth/proliferation, the synthesis of proteins, lipids, 
and nucleotides, as well as being a regulator of autophagy (cell self-eating). Activation of the mTOR 
pathway promotes cell proliferation/growth and inhibits autophagy as reviewed in Saxton and Sabatini, 
2017. Conversely, during inhibition of the pathway using Rapamycin, cellular proliferation and growth 
are limited and inhibition of autophagy by mTOR is reduced.  
  Rapamycin (Figure 1-1) was discovered in 1975 by Sehgal et al (1975)., eleven years after a 
Canadian expedition to collect soil samples from Easter Island. This macrocyclic lactone was extracted 
from the bacterium Streptomyces hygroscopicus and was discovered to have antibacterial properties. 
This antibacterial property was due to the ability of Rapamycin to selectively inhibit the ubiquitous 
mTOR pathway (Loewith and Hall, 2011). Since this discovery, the drug has been repurposed as an 
immunosuppressant during kidney transplantations (Abraham and Wiederrecht, 1996), and was 
suggested as a tool to slow cancer growth – inspiring the creation of Rapamycin paralogs, or ‘Rapalogs’, 
better tailored for treatment of cancers (temsirolimus, everolimus) (Graziani, 2009; Li et al., 2014).  
However, the impact of Rapamycin as well as the Rapalogs has not been investigated at the genomic 
level, and with this information, new functions and applications of Rapamycin may be discovered. 
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Figure 1-1: Chemical Structure of Rapamycin. Rapamycin is a macrocyclic lactone discovered from a soil 
sample found on Easter Island (Rapa Nui) in the Pacific Ocean. (Credit: https://www.sigmaaldrich.com) 
 
1.2.1 The mTOR Complexes: TORC1 and TORC2 
 The mTOR pathway contains two major complexes, known as mTOR Complex 1 (mTORC1) and 
mTOR Complex 2 (mTORC2). Both complexes are responsible for regulating the health of cells; however, 
this is accomplished differently in each case. mTORC1 regulates the status of the cell and when active 
positively regulates translation, nucleotide synthesis, lipid synthesis, glucose metabolism, growth and 
proliferation of cells while downregulating autophagy (as reviewed in (Saxton and Sabatini, 2017)). 
mTORC2 acts on downstream effectors to positively regulate ion transport, glucose metabolism, cell 
migration and cytoskeletal rearrangement, and to negatively regulate autophagy as reviewed in Oh and 
Jacinto, 2011. mTOR function has a significant impact on the status of the cell; however, how this 
complex regulation relates to maintaining cellular health and cellular ageing has yet to be established. 
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1.2.1.1 Up-stream regulation of mTORC1  
  As a nutrient sensing hub, mTORC1 receives signals from many up-stream inputs (Figure 1-2). 
The signal from many up-stream effectors act on a complex of Tuberous sclerosis proteins 1 and 2 
(TSC1/2) (as reviewed in (Huang and Manning, 2008)). When activated, this TSC complex inhibits the 
activity of Ras homolog enriched in brain (Rheb). This inhibition prevents Rheb from activating mTORC1. 
This TSC complex integrates positive growth signals (inactivates TSC, activates mTORC1) and negative 
growth signals (activates TSC, inhibits mTORC1) (Inoki et al., 2006). Upon activation, epidermal growth 
factor receptor (EGFR) transduces a signal through the MAPK (Mitogen-activated protein kinase) 
cascade and inhibits TSC and activates mTORC1. AMP-activated protein kinase (AMPK) acts as an energy 
sensor for mTORC1 activity by detecting the ratio of AMP to ATP and inhibiting mTORC1 activity by 
activating TSC in the absence of adequate ATP (Gwinn et al., 2008; Inoki et al., 2006). p53 (tumor protein 
53) acts up-stream of AMPK and detects DNA damage, indirectly inhibiting mTORC1 activity in the 
presence of DNA damage (Akeno et al., 2015; Feng et al., 2005; Hasty et al., 2013). Hypoxic conditions 
are capable of inhibiting mTORC1 activity through regulated in development and DNA damage 
responses 1 (REDD1/DDIT4), which activates TSC, resulting in inhibition of Rheb and mTORC1 
(Brugarolas et al., 2004). Cytoplasmic arginine and leucine regulate mTORC1 activity through the 
RAGulator complex which in turn is regulated through the CASTOR/GATOR pathway (Chantranupong et 
al., 2016). CASTOR, cellular arginine sensor for mTORC1, directly senses cytoplasmic arginine levels, 
resulting in modulation of mTORC1 function. GATOR, GTPase activating proteins toward Rags complex, 
directly senses cytoplasmic leucine, also modulating mTORC1 function. Increased levels of arginine 
result in the activation of mTORC1. Leucine is also associated with this pathway and increased leucine 
levels repress Sestrin2, also resulting in activation of mTORC1 (Wolfson et al., 2016). In summary, 
mTORC1 senses for adequate energy, amino acids (leucine and arginine) (Jewell et al., 2015; Jewell et 
al., 2013), growth signals, while also modulating the activity of mTORC1 to accommodate for stressors 
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such as DNA damage and hypoxic conditions (as reviewed in (Saxton and Sabatini, 2017; Zoncu et al., 
2011). mTORC1 is a sensing hub for many signals and is able to monitor the environment around the cell 
to allow for appropriate proliferation and growth to occur. mTORC1 also has the ability to slow cell 
proliferation when the situation is unfavorable or if adequate signals are given to change the stance of 
cells to repair and maintenance from growth/proliferation. 
 
 
Figure 1-2: Upstream Regulation of mTORC1. A summary of the multiple upstream effectors of 
mechanistic Target of Rapamycin Complex 1 (mTORC1). Positive Growth signals (activators) of mTORC1 
are shown in blue. Negative growth signals (in-activators) of mTORC1 are shown in red. mTORC1 is a 
central nutrient sensing hub that mediates cellular response according to nutritional availability and 
environmental conditions.  
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1.2.1.2 mTORC1 control of translation 
 mTORC1 is responsible for modulating translation rates through ribosomal protein-S6-kinase 
beta (S6K). Active mTORC1 phosphorylates S6K which phosphorylates ribosomal subunits to initiate 
translation (Holz and Blenis, 2005; Magnuson et al., 2012). Active mTORC1 also promotes translation 
indirectly by activating eukaryotic translation factor 4E (elF4E), which promotes 5’ cap-dependent 
translation by recruiting ribosomes. Both of these mechanisms indicate the vital role active mTORC1 has 
in promoting translation (Wraught and Gingras, 1999) and provide further evidence that mTORC1 has 
significant control and involvement in major cellular processes. 
 
1.2.1.3 mTORC1 control of autophagy 
 Active mTORC1 suppresses autophagy (defined as cell self-eating) (Jung et al., 2010). Autophagy 
has been shown to be central for protein homeostasis in times of cellular stress. Furthermore, 
autophagy is involved in the elimination of damaged organelles such as mitochondria (mitophagy) and is 
linked to health- and life-span extension. When mTORC1 is activated by adequate nutrient presence, it 
inhibits autophagy by inhibiting several proteins responsible for driving autophagy (ULK1: Unc-51 like 
autophagy activating kinase 1, TFEB: Transcription Factor EB, UVRAG: UV Radiation Resistance 
Associated Gene) and Proteasome assembly (Erk5: Mitogen activated protein kinase 7) (Martina et al., 
2012; Noda, 2017). While mTORC1 is not activated, decreased phosphorylation of ULK1 leads to 
increased ULK1 activity resulting in phosphorylation of downstream activators of autophagy. Therefore, 
mTORC1 serves a central role that balances protein translation (active mTORC1) and protein recycling 
and organelle degradation (inactive mTORC1) by autophagy.  
 
 
7 
 
1.2.2 Rapamycin and its inhibition of mTORC1 
  Despite the similar composition of the two mTOR complexes, Rapamycin selectively inhibits 
mTORC1 due to its preferential binding of the FK-binding protein 12 (FKBP12), resulting in partial 
blocking of the active site of mTOR upon binding the FKBP12-Rapamycin pair to the complex (Dumont, 
1995). mTORC2, though similar, is not directly inhibited by this mechanism due to its utilization of 
Rapamycin insensitive companion of mTOR (Rictor) in its complex rather than regulatory protein 
associated with mTOR (Raptor). Rictor uniquely occludes the binding site (an FRB homology domain on 
mTOR) to the FKBP12/Rapamycin pair (Reviewed in Saxton and Sabatini, 2017). However, there is 
discussion on whether long term treatment of cells or patients would lead to inhibition of mTORC2 as 
well (Sarbassov et al., 2006). Due to its specificity, Rapamycin is a powerful tool for investigating the 
effects of mTORC1 on the genome and cellular status. 
 
Figure 1-3: Rapamycin inactivates growth and proliferation of cells and promotes autophagy. mTORC1 
serves as a nutrient sensing hub responsible for driving growth and proliferation when adequate 
nutrition is available. By treating with Rapamycin, cells bypass nutrient sensing and switch from 
promoting proliferation and growth (blue) to promoting maintenance and repair (red).  
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1.2.3 Rapamycin impacts gene expression patterns of normal dermal fibroblasts 
  Earlier work from the Eskiw Lab (Gillespie et al., 2015) characterized genome wide gene 
expression changes in normal primary fibroblast cells following treatment with 500 nM Rapamycin. 
Following RNA-sequencing, it was revealed that treatment with Rapamycin induced the expression of 
many genes regulated by the Signal Transducer and Activator of Transcription 5A/B (STAT5A/B) 
regulation, including several cytokine genes as well as the Leukemia Inhibitory Factor (LIF). Using Kyoto 
Encyclopedia of Gene and Genome (KEGG) terms, a link to mTOR was discovered through the 
significantly enriched PI3K-AKT signaling terms. Furthermore, rather than driving a specific cytokine 
pathway, treatment with Rapamycin provoked a wide array of enrichment across cytokines. How 
Rapamycin functions, and the rationale for its putative anti-aging properties, may lay in some 
unexamined connection between these up-regulated genes. 
 
1.2.4 Rapamycin parallels Caloric Restriction 
  
  Caloric Restriction (CR) is defined as a reduction of calorie intake without causing malnutrition. 
CR treatment been shown to ameliorate ageing phenotypes in several model organisms (Colman et al., 
2009; Sohal and Forster., 2014; Gilmore and Redman., 2018; Arlia-Ciommo et al., 2018; Fontana and 
Partridge, 2015); however, caloric restriction diets are difficult to follow. As a result, there is interest in 
discovering drugs that mimic the effects of CR without the need for strict dietary plans; called CR 
mimetics (CRM).. Several CRM drug candidates have been identified, including Rapamycin (Kitada and 
Koya, 2013). Rapamycin is thought to parallel CR by downregulation of the mTORC1 pathway. CR lowers 
mTORC1 pathway activity by reducing the amount of cellular energy (AMP:ATP ratio) sensed upstream 
of mTORC1 (Blagosklonny., 2010). Functionally, Rapamycin treatment uncouples molecular 
nutrient/energy sensing which induces a perceived state of lower cellular energy and nutrient 
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availability, regardless of actual nutrient and energy presence. Rapamycin, and the class of drugs with 
similar structure to rapamycin (called rapalogues) would therefore be a candidates to reduce the ageing 
phenotype without requiring a restriction of caloric intake.  
1.3 Genome Organization 
 The human genome consists of 3.6 billion nucleotide base pairs (bp) encoded on 23 pairs of 
chromosomes: 22 autosomal pairs and a pair of sex chromosomes. These chromosomes range in size 
from 250 million to 50 million bp. This linear genetic sequence is formed from 4 distinct nucleotides; 
Thymine (T), Adenine (A), Cytosine (C), and Guanidine (G) and forms a duplex with a complementary 
strand through hydrogen-binding. Hydrogen-bonding occurs between pairs of these nucleotides, 
containing one purine (A or G) and one pyrimidine (T or C) per pair (AT or GC), and dictates the 
formation of the canonical deoxyribonucleic acid (DNA) double-helix (Watson and Crick, 1953). This 
double-helix has a diameter of 20 Angstrom (Å) or 2 nanometers (nm), rotates roughly every 10 
residues, and contains two types of grooves; the major groove and the minor groove.  The unique 
characteristics and three-dimensional structure of DNA allows a variety of functions to be possible, 
including annealing and denaturation of complementary strands as required, protein binding at major 
grooves of DNA, and sequence repair based on the complementary nature of the genetic code (as 
reviewed in (Travers and Muskhelishvili, 2015). 
  DNA is the ‘blueprint’ for life and its sequences code for genes and regulatory elements. By 
combining these elements, genes can be regulated and produced in response to stimuli, or during 
development. To date, many factors that affect disease state and phenotypic difference have been 
attributed to portions of the genome previously thought to have no function, positioned outside of the 
coding region of genes, and were previously named ‘junk DNA’. A transition has been made from 
interpreting non-coding sequences as ‘junk’ to new and complicated roles in genomic function (as 
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reviewed in (Palazzo, 2014)). When accounting for ~2% of genetic code being protein coding genes, it 
can be estimated that ~98% of the genome is non-coding material – 3.53 billion of 3.6 billion base pairs.  
  In humans, DNA forms a complex with histone (H) proteins to form chromatin. Chromatin is a 
complex of DNA and octamers of histone proteins containing 2 copies of H2A, H2B, H3, and H4 wrapped 
by 146 base pairs of DNA (as reviewed in (Kouzarides, 2007)). This association results in the ‘beads on a 
string’ 11 nm fiber. Chromatin is classified into either euchromatin or heterochromatin depending on 
the level of DNA condensation and presence of additional factors. Euchromatin is less compacted and 
more ‘open’ and contains expressed genes, whereas heterochromatin is highly compacted and 
resultantly ‘closed’ and contains genes that are inactive (as reviewed in (Margueron and Reinberg, 
2010)). The ‘closed’ state of heterochromatin denies RNA polymerase II and other factors access to the 
contained genes, subsequently silencing them. Heterochromatin is further divided into either 
constitutive or facultative heterochromatin. Constitutive heterochromatin occurs in gene poor regions 
such as the centromeres or telomeres on chromosomes and is generally conserved between cell types. 
Whereas facultative heterochromatin varies between cell types and its formation plays a role in 
silencing gene expression and establishing cell type (Dixon et al., 2015; Kramer, 2016; Shchuka et al., 
2015). For example, one of the two X chromosome in female somatic cells undergoes silencing by 
heterochromatin formation (Cheng and Disteche, 2004). Both facultative and constitutive 
heterochromatin are enriched with the histone linker (H1), which forms a chromatosome when 
combined with the nucleosome, and potentially further condenses the 11 nm fiber into the more highly 
compact 30 nm solenoid or zig-zag structure.  
  Chromatin structure is highly dynamic and is regulated at several levels, such as through the 
exchange of histones and the introduction of functionally unique histone variants, and by chromatin 
remodeling complexes (CRC). The exchange of histones, also called ‘nucleosome dynamics’, facilitates 
the maintenance of chromatin and histone exchange/turnover within transcriptionally active regions. 
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This also allows the introduction of histone variants that differ by only a few amino acids into the 
nucleosome. Examples include the chromatin remodeler recruiting H2A.Z, which is integrated into 
nucleosomes near nucleosome-depleted regions (NDRs) and facilitates the activation of genes by 
antagonizing DNA methylation (Venkatesh and Workman, 2015; Zilberman et al., 2008). H3.3 which is 
associated with active genes, and macroH2A which is involved in the inactivation of the X-chromosome 
(as reviewed in (Venkatesh and Workman, 2015)). Another actor regulating chromatin structure lays in 
the chromatin remodeling complexes, such as Inositol requiring 80 (INO80) or Brahma-related gene 1 
(BRG1- or hBRM)-associated factors (BAF) (Kapoor et al., 2013). These complexes utilize ATP, as the 
association between the positively charged histones and negatively charged DNA is energetically 
favourable and resistant to alteration, to slide and/or evict nucleosomes from a target region through 
several different mechanisms. Other factors such as TATA binding protein (TBP) act in tandem with 
remodeling complexes to facilitate nucleosome sliding (as reviewed in (Juven-Gershon and Kadonaga, 
2010)). 
  Above the linear sequence and chromatin organization of the genome is the epigenetic code. 
The epigenetic code is a series of post-translational modifications (PTMs) applied to N-terminal peptide 
tails of the histones (as reviewed in (Bannister and Kouzarides, 2011)). These modifications may occur 
on several different residues such as lysine (K) and arginine (R) and include acetylation, methylation, 
phosphorylation, and ubiquitination (as reviewed in (Kouzarides, 2007)). The result of these 
modifications is dependent on the specific residue modified as well as the type of modification and the 
local genomic elements. For example, acetylation of lysine residues regulated by histone acetyl 
transferases (HATs) and histone deacetylases (HDACs) interrupts the positive charge of the lysine 
residues and weakens the interaction with the negatively charged DNA. Methylation states can occur as 
mono-, di-, or tri-methylated at lysine or arginine residues and rather than altering the charge status of 
the residue, the methylation facilitates the binding of proteins. Depending on the specific lysines or 
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arginines being modified, methylation states may activate or repress transcription. For example, H3K9 
acetylation is associated with actively transcribed regions and tri-methylated H3K9 is associated with a 
region of repressed expression and heterochromatin.  Furthermore, sections of DNA known as CpG  
islands (a repeated CG motif) can undergo methylation to silence transcription of nearby genes and 
block the binding of proteins (Saxonov et al., 2006). CpG islands are usually positioned near the 
transcription start site of genes and are capable of undergoing methylation at C residues to inhibit 
transcription.  
 The human genome is compartmentalized into the nucleus; a double lipid bilayered organelle 
that provides a highly controlled environment for the genome. The nucleus is known to be highly 
organized and the work of many labs has opened this field into many directions, from genome topology 
in the nucleus to characterizing accumulation of factors at precise nuclear locations (Albiez et al., 2006; 
Bolzer et al., 2005; Cremer and Cremer, 2010; Cremer et al., 2018; Dundr, 2012; Guo et al., 2011; 
Osborne et al., 2004; Solovei et al., 2009; Spann et al., 2002; Ulianov et al., 2016; Zorn et al., 1976). 
While the systems of nuclear organization are still being investigated, several aspects have emerged on 
how the organization of such a fundamental organelle is orchestrated. One such example is the 
nucleolus. The nucleolus serves as a prototypical example of nuclear organization. The acrocentromeric 
chromosomes (13, 14, 15, 21 and 22) containing the rRNA genes organize to a distinct nuclear location. 
Nucleolar organization can coalesce into one of several nucleoli depending on cell type and disease 
state. Upon coalescence of the nucleolar organizing regions (NORs) a functional nucleolus is formed 
which facilitates ribosome biogenesis (Floutsakou et al., 2013). This provides an example of nuclear 
organization and also an example of a conserved biological process that utilizes organization of 
chromatin for a functional purpose.  
  Nuclear lamina represent another component of nuclear organization (as reviewed in (Dechat et 
al., 2009)). Lamins are proteins that form a network at the inner face of the nuclear membrane, 
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providing a scaffolding site that serves as an anchorage point for heterochromatin domains. The 
significance of this scaffolding is seen in the pre-mature ageing disease Hutchinson-Gilford Progeria 
Syndrome (HGPS), caused by a point mutation in the Lamin A/C gene, leading to the expression of a 
truncated form of the Lamin A/C protein (Liu et al., 2005). The aberrant accumulation of this protein in 
the lamina results in dys-regulation of several essential nuclear functions including, transcriptional 
regulation and DNA repair (Buchwalter and Hetzer., 2017; Weaton et al., 2017). 
  The nucleus is a crowded organelle requiring spatiotemporal organization of many factors 
(Hancock, 2014; Spitz and Furlong, 2012). It potentially contains between several hundred to thousands 
of varieties transcription factors, most of which are currently uncharacterized, that must be able to 
locate and bind the correct genomic loci (Lambert et al., 2018; Vaquerizas et al., 2009).  It also must 
orchestrate mRNAs to be properly localized to and processed by splicing machinery prior to export from 
the nucleus (as reviewed in (Katahira, 2015)). The nuclear environment facilitates the compaction and 
regulation of DNA by the formation euchromatin and heterochromatin; a dynamic and highly tailored 
process. To this end the nuclear environment must also facilitate the integration and renewal of 
histones and histones variants with functional consequences, such as histone tagging of double strand 
breaks (DSB) which are then repositioned to distinct nuclear sites for repair (Marnef and Legube, 2017; 
Redwood et al., 2011). Historically it has been suggested in textbooks that the genome is condensed to 
allow it to fit inside of the nuclear volume,  additionally, it could be said that the compaction of the 
genome also allows room for other factors to be present (Dehghani et al., 2005). 
1.3.1 Protein Coding genes 
 It has been predicted that the human genome contains anywhere between 19,000 to 25,000 
protein coding genes that code the human ‘proteome’ – the sum of all proteins expressed by a cell 
(Clamp et al., 2007; Kim et al., 2014). From these 19,000 to 25,000 possible genes, up to 300,000 
peptide and proteins may be produced. These protein genes include sequences that code for mRNA 
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consisting of exons which contain codons that encode amino acid sequence, introns which are contained 
between exons and excised during splicing events, and poly-A tails that regulate mRNA half-life. Intron 
and exon splicing during pre-mRNA processing allows for protein variants through alternative splicing 
that selects for different combinations of exons to form the final coding DNA sequence (CDS) (as 
reviewed by (Bentley, 2014; Shi, 2017)). mRNA additionally contains two un-transcribed regions (UTR), 
known as the 5’ and 3’ UTR, which flank the protein coding sequence. The 5’ UTR contains the initiation 
sequence (‘Start codon’) AUG which codes for the amino acid methionine. The function of the 3’ UTR 
has been implicated in mRNA stability and translation efficiency (Matoulkova et al., 2012). The output 
from this process is an amino-acid chain or peptide capable of folding, with or without chaperones, into 
a functional enzyme capable of catalyzing chemical reactions. The amino acids contained in this peptide 
sequence may include factors such as a nuclear localization signal (NLS) or glycosylation sites that 
encode where enzymes should localize and operate (as reviewed in (Bauer et al., 2015)). The linear 
sequence of the genome provides the potential for protein splicing variants (different combinations of 
exons) to be produced from a single protein coding gene. This splicing is a highly organized, co-
transcriptional, three-dimensional event in the nucleus, requiring the co-localization of many factors and 
resulting in several hundred-thousand proteins being produced from a much lower number of protein 
coding genes (as reviewed by (Spector and Lamond, 2011)).  
 
1.3.2 Promoters 
 To regulate the expression of mRNA-producing genes the genome contains promoters and 
enhancers. Promoters occupy regions up-stream of genes and facilitate the binding of protein factors as 
well as RNA Polymerases (such as RNA Polymerase II). For protein-coding genes, these regions occur 
within short distance of the gene and contain the transcriptional start site (TSS), the location where the 
polymerization of RNA begins (as reviewed in (Blackwood and Kadonaga, 1998; Kugel, 2017)). Many 
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(~46%) human genes contain a 17 bp sequence known as an initiator element (Inr) that provides a 
binding site for factors that summarily recruit the basal transcription machinery (BTM) (Kugel, 2017; 
Sikorski and Buratowski, 2009; Smale and Baltimore, 1989). Many human promoters contain a TATA-box 
or a TATA-like-box – a sequence in the promoter region that contains a conserved TATAA sequence 
within 50 base pairs up-stream of the TSS (Yanga et al., 2007). The TATA-box and TATA-box-like 
sequences has been estimated occurring in ~24% of genes; however, this number varies (11.6% - 76%) 
depending on the method and parameters of estimation (Yanga et al., 2007). The TATA box provides a 
docking site for the TATA binding protein (TBP). This binding introduces a bend in the DNA and facilitates 
transcriptionally-permissive unwinding of the DNA strand. For a promoter to be properly utilized, it 
requires the recruitment of relevant factors at specific sequences. These factors must somehow 
navigate the chaos of the nucleus to find the relevant DNA-binding domain or mediator protein to 
facilitate transcriptional activation by the promoter. 
 
1.3.3 Enhancers 
 Enhancers are regions of nucleotide sequences distal to a gene with motifs that are recognized 
by DNA-binding proteins, such as transcription factors (Blackwood and Kadonaga, 1998; Pennacchio et 
al., 2013). Upon introduction of DNA-bending proteins and the binding of transcription factors at the 
enhancer, enhancers are held in close physical proximity to their relevant promoter by looping of the 
DNA strand. This looping is maintained by transcription factors, as well as other proteins such as the 
Mediator complex (as reviewed in (Allen and Taatjes, 2015)). The formation of this three-dimensional 
folding has dramatic effects on gene expression and increases the likelihood of gene transcription when 
formed. Enhancers have been attributed roles in differentiation and development, wherein differential 
enhancer utilization may guide tissue differentiation or developmental variants of genes. Enhancers 
have also served a role in evolution through the formation of a novel regulation for a gene. Examples of 
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these types of enhancer utilization can be found in T-helper cell differentiation (Spilianakis and Flavell, 
2004; Spilianakis et al., 2005), and the timed expression of the globin genes during development (Carter 
et al., 2002; Tolhuis et al., 2002). It has been observed that some genes have multiple enhancers 
available which may provide a role in developmental or in alternate usage when one enhancer is 
unavailable. These are referred to as ‘Shadow Enhancers’ and are currently under investigation to 
discover if their existence is a redundancy or a functional element (Barolo, 2012; Cannavo et al., 2016).  
Additionally, silencer elements have also been identified and are capable of inhibiting transcription by 
blocking the binding of RNA Pol II to the promoters of genes. Enhancers, mediated by transcription 
factors, provide powerful elements of gene regulation. Together they are capable of being tissue specific 
and able to enhancer the transcription of multiple difference genes. Importantly, these regulatory 
mechanisms require the three-dimensional organization (looping) of the genome. 
 
 
 
Figure 1-4: Enhancers act on gene promoters. Genomes are capable of ‘looping out’ sequences of DNA 
to facilitate contact between different genetic elements, such as enhancers and promoters, to increase 
transcription. This contact is facilitated by transcription factors that bind to specific DNA motifs and 
other proteins that mediate or bridge contact between the transcription factors or genetic elements.  
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1.3.4 Insulators/CTCF Sites 
 Insulator elements, sometimes referred to as boundary elements, are regions of the genome 
that ‘block’ the erroneous interaction between an enhancer and promoter (Barkess and West, 2012). 
These regions contain sequences recognized by CCCTC-binding factor (CTCF) as well as other factors 
(Dunn and Davie, 2003; Herold et al., 2012; Kim et al., 2007). CTCF, along with the Cohesion complex, 
bind these insulator elements and through CTCF dimerization localize them together to form a loop 
(Nativio et al., 2009; Rubio et al., 2008). The formation of this loop compartmentalizes a section of the 
genome and resultantly affects gene regulatory mechanisms by promoting internal enhancer-promoter 
interactions while discouraging external interactions (as reviewed by (Ong and Corces, 2014; Phillips and 
Corces, 2009)). This topological regulation has been attributed significant roles in complex biological 
processes such as V(D)J (Variable, diversity, and joining) recombination (discussed later) (Guo et al., 
2011). Loss of insulator elements has also been discovered as the cause of certain disease states, where 
an enhancer acts inappropriately over a deleted boundary and on a nearby gene such as seen in adult 
onset leukodystrophy (Giorgio et al., 2015). These examples show the importance of insulator elements 
in mediating genome organization and function. Insulator elements may also provide a role in tissue 
differentiation and development by regulating enhancer looping that will be required at a later point 
(Doerks et al., 2002; Vogelmann et al., 2011). Binding of the CTCF protein to the CTCF element is 
disrupted by CpG methylation on the element and is a known component of tissue differentiation 
commitment (Phillips-Cremins et al., 2013). 
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1.4  Gene Regulation and Transcription 
1.4.1 Transcription 
 Transcription is the process by which a targeted region of DNA is transcribed into RNA, prior to 
up-stream processes such as protein translation. To accomplish transcription, the human genome 
encodes at least three functional RNA polymerases with distinct biological roles, as well as various 
transcription factors. Two of the RNA Polymerases present, RNA Polymerase I and III, are responsible for 
transcribing rRNA used in ribosome biosynthesis and tRNA which carries specific amino acids prior to 
their utilization in the growing peptide of protein translation (Cramer et al., 2008; Melnik et al., 2011). 
The remaining polymerase, RNA Polymerase II is responsible for transcribing protein coding genes into 
mRNA.  
  The process of mRNA transcription is divided into three phases; initiation, elongation, and 
termination. Prior to initiation several components assemble at a site up-stream of a gene known as the 
core promoter. These factors include general transcription factors (TFIIA, -B, -D, -E, -F, -H) and RNA 
polymerase II, that together form the basal transcription machinery (BTM) (Goodrich and Tjian, 1994; 
Shandilya and Roberts, 2012; Villicaña et al., 2014). Following this assembly RNA Polymerase II will 
initiate and repeatedly produce short abortive transcripts until a long enough transcript is produced and 
RNA Pol II escapes the promoter to drive the process forward into the elongation phase (as reviewed by 
(Brookes and Pombo, 2009)). Transcription is terminated upon reading of a polyadenylation signal, 
subsequent cleavage of the mRNA transcript, and polyadenylation of the mRNA  (as reviewed by 
(Richard and Manley, 2009)). Transcription is only possible when all the necessary factors gather. 
Considering the number of factors involved it would seem natural and efficient that factors are either 
collected at a tailored nuclear location, or mechanisms exist to rapidly drive factors to needed locations. 
Both of these necessitate organization of the nucleus. 
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1.4.2 Transcription Factors 
 Transcription factors are proteins containing DNA-binding domains (DBD) as well as other 
domains that act to promote and/or regulate transcriptional activity, such as adaptor sequences that 
facilitate binding with other proteins (as reviewed in (Lambert et al., 2018). The DBD provide specificity 
for transcription factors to bind specific sequence motifs up-stream of the transcriptional start site (TSS) 
of a gene or at distal enhancers. These sequences are referred to as response elements or more 
descriptively as transcription factor binding sites (Inukai et al., 2017). Upon transcription factor binding, 
other factors (such as the mediator complex) are recruited to the gene to prepare for transcription. 
Transcription factors react to cellular signaling pathways and locate to the nucleoplasm to exert their 
effect on the expression of relevant genes. These factors may act as either activators or repressors, or 
pleiotropically, wherein one factor can up-regulate a certain subset of genes while simultaneously 
down-regulating another subset (Lambert et al., 2018). Additionally, transcription factors may require 
co-activators or co-repressors to achieve a function on gene regulation. For example, STAT5A transduces 
up-stream signals from a Janus Kinase (JAK), in the form of a phosphorylation on STAT5A, causing two 
STAT5A proteins to dimerize and enter the nucleus where it binds a STAT5A response element (Schindler 
et al., 2007). Transcription factors provide a powerful tool for gene regulation as bind to specific 
sequences of DNA, activate their effect in response to specific stimuli, and are capable of combining 
with other factors to further tailor their response on the transcription of a gene. To have any effect on 
their target of interest, transcription factors must be localized to genes and other relevant genetic 
elements. 
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1.5 Genome Topology 
  Genome topology is a relatively new field. Its investigations are centered how the genome is 
organizes inside the nuclear volume and how this organization relates to cellular function and responses 
to stimuli. One of its core techniques, DNA Fluorescence in situ hybridization (DNA-FISH), has allowed 
characterization of chromosome positioning and space occupancy in the nucleus (Bolzer et al., 2005; 
Cremer and Cremer, 2001; Cremer et al., 2006; Solovei et al., 2009). Investigations into genome 
topology have further illuminated the nucleus as a highly organized compartment capable of responding 
to stimuli in a repeatable manner.  
 
1.5.1 Chromosomes and Chromosome Territories 
 Contrary to the model commonly portrayed in textbooks, featuring unwound chromosomes 
expanding entropically to fill the nucleus, chromosomes preferentially occupy local regions known as 
chromosome territories (CTs) (Bolzer et al., 2005; Cremer and Cremer, 2010; Cremer et al., 2006; Zorn et 
al., 1976). These territories are distinct; however, mingling of chromosome strands may occur inside the 
territory or at territory boundaries. The position of these territories is non-random and have been 
observed to change position following treatment (Gillespie et al., 2015; Mehta et al., 2010). Correlating 
nuclear positioning of chromosome territories to gene expression and function is not clear, but it has 
been suggested that localization to the periphery of the nucleus correlates to gene-poor chromosomes 
(low gene density) or decreased gene expression and silencing, while localization to the interior is 
correlated with gene-rich chromosomes (higher gene density) and increased gene expression (Cremer et 
al., 2003; Croft et al., 1999). It has been observed that the peripheral localization of genes with low 
expression levels is consistent with the increased quantities of heterochromatin found at the nuclear 
periphery (as reviewed in (Bridger and Bickmore, 1998)). However, notions of global radial positioning 
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correlating to gene expression are challenged by the expression of genes located within peripheral 
regions, and by complications introduced by gene positioning correlating to tissue differentiation 
irrelevant of expression (as reviewed in (Mahy et al., 2002)).  The investigations made into genome 
organization and chromosome territory position have highlighted the dynamic ability of the genome to 
reorganize in response to stimuli. 
 
Figure 1-5: Chromosome territories. Illustration of imagined chromosome territory positioning in the 
nucleus. Chromosomes occupy distinct territories in the nucleus. Each colored section represents a 
chromosome and how it may occupy a territory in the nucleus. Chromosome territories can alter 
position in response to stimuli.  
 
 
1.5.2 Chromosome Territory Repositioning 
 Chromosomes occupy specific territories in the nucleus, these are known as chromosome 
territories (CT). During mitosis the organization of these chromosome territories is lost until re-
established early in the G1 phase of the cell cycle. The exact mechanism of chromosome repositioning is 
unknown, as is the putative nuclear framework to guide and organize the repositioning. However, it has 
been shown by Mehta and colleagues (Mehta et al., 2010) that disruption of myosin with siRNA (small 
interfering RNA) interference resulted in no repositioning of chromosomes in response to cellular 
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stimuli. Under normal conditions, chromosomes are capable of re-positioning in response to stimuli 
(such as decreased serum levels) within 15 minutes and  this process does not require mitosis for re-
organization.  This work established that chromosomes can move rapidly in response to stimuli and that 
a process utilizing myosin is involved. 
  Chromosome territory positioning during interphase is dynamic and repeatable. It has been 
shown previously in our lab and others that upon induction of quiescence chromosomes 18 and 10 
reposition predictably, with chromosome 18 assuming a more internal position, and chromosome 10 a 
more peripheral position. A similar repositioning of chromosomes has been observed in our lab 
following treatment with Rapamycin (Gillespie et al., 2015; Mehta et al., 2010). This informs that the 
movement of a chromosome has a functional purpose and is non-random. 
  Chromosome territories have the capability to interact with their neighbors. This is known as 
chromosome territory intermingling and involves the looping out of chromosomal segments from the 
core of the chromosome territory to an intermediate position between two neighboring chromosomes 
(as reviewed by (Belyaeva et al., 2017). Boundaries of chromosome territories allow intermingling with 
strands from other chromosomes to occur on the surface. These strands can extend long distances 
across the nuclear volume to invade a chromosome territory. Each of these interactions may represent 
specific functions related to gene expression (discussed in section 1.7). One such function would be the 
interaction between a promoter and an enhancer which requires two chromosomes to be in close 
physical proximity in the nuclear volume, as well as precise organization of the genome. An example of 
this is found in T-helper cells, where regulatory elements on chromosome 11 localize to the promoter of 
IFN-γ chromosome 10 (Spilianakis et al., 2005). Another function is found in the co-localization of like-
regulated genes from different chromosomes. This was observed at transcription factories (discussed in 
section 1.7), where like-regulated genes and the necessary transcriptional machinery was concentrated. 
Changes to chromosome territory positioning may facilitate new or different intermingling between 
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chromosomes, such as bringing an enhancer from one chromosome into proximity of a promoter on a 
different chromosome. Additionally, it may bring like-regulated genes together in three-dimensional 
space, such as a shared site of transcription. 
 
1.5.3 Higher Order Genome Topology 
  With the advent of Chromosome Conformation Capture (3C) (Dekker et al., 2002), it became 
possible to investigate topology at the sub-chromosomal level. Previously, investigations relied on DNA-
FISH that fundamentally lacked the optical resolution to characterize co-localization of elements of 
interest, such as a promoter and an enhancer (Figure 1-6). Since its inception, 3C has spawned a series 
of derivative techniques, notably Hi-C (Lieberman-Aiden., 2009), that allows topological characterization 
of entire genomes. These investigations have revealed evolutionarily conserved domains of the genome 
that encompass up to several genes and other genetic elements (Dixon et al., 2012) and illuminated 
processes controlling development and cellular differentiation. Furthermore, dysregulation of genome 
topology has also been tied to several disease states, such as the fusing of the index finger and thumb 
which was recapitulated in mice (as reviewed in (Lupianez et al., 2016)). Investigation of sub-
chromosomal topology paves the way for understanding complicated and currently under-characterized 
mechanisms of gene regulation. 
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Figure 1-6: From chromosome territory to sub-chromosomal topology. Chromosomes occupy distinct 
territories in the nucleus. The positioning of these chromosomes has been related to cellular health, 
status, and transcriptional profile. Two techniques, DNA-FISH and Chromosome Conformation Capture 
(3C) can be used together to bridge large-scale organizational changes of whole chromosomes to 
alterations in the topology of genetic elements, such an enhancers and promoters of genes.  
 
1.6 Long Range Interactions 
 Long range chromatin interactions are interactions between two sections of chromatin that are 
brought together in three-dimensional space, often ‘looping out’ sequences contained between the 
interacting sites (Carter et al., 2002; Spilianakis and Flavell, 2004; Tolhuis et al., 2002). Interactions can 
be defined as cis- (occurring between two points on the same chromosome) and trans- (occurring 
between two points, each on different chromosomes). These interactions are mediated and maintained 
by proteins capable of targeting distinct sequences of chromatin such as TFs and CTCF. These 
interactions can be divided into several categories. Firstly, there are interactions that occur between 
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promoters and up to several elements (enhancers and silencers) that regulate gene expression and 
result in genome folding  (Blackwood and Kadonaga, 1998; Raab and Kamakaka, 2010). Rather than 
directly affecting gene expression, insulators flank and compartmentalize local regions to form a loop. 
These ‘insulated’ loops often contain promoters and enhancers. This insulation effect is seen in the 
action of the CTCF protein, which binds chromatin at distinct CTCF-sites (a 14 bp sequence). These sites 
are then brought together in three-dimensional space to form a loop through the dimerization of two 
opposite-facing CTCFs occupying distal sites of the genome (Holwerda and de Laat, 2013; Ong and 
Corces, 2014; Phillips and Corces, 2009). The formation of this compartmentalized loop promotes the 
interaction between internal elements, such as promoters and enhancers, while blocking external 
enhancer elements from interacting with the region (as reviewed by (Dunn and Davie, 2003; Herold et 
al., 2012)). Long-range interactions instruct upon proper gene regulation and the loss of insulator 
elements has been tied to disease states caused by the formation of inappropriate long-range 
interactions. Long-range interactions promote the efficiency of transcription (as reviewed in (Pennacchio 
et al., 2013), and in one experimental case the addition of an enhancer element resulted in ~13 fold 
increase in the expression of the collagen II gene in rats (Horton et al., 1987). These observations 
connecting long-range interactions and transcription validate the importance of 3D organization and 
chromatin interactions in regards to facilitating gene expression. Furthermore, cellular health and 
disease may be interpretable by investigating these organizational events. 
 
1.7 3D Organization and Gene Expression   
 It is clear that the organization of genetic material inside the nucleus provides a function and 
informs on cellular status. We can currently observe this organization at two experimentally 
characterizable levels. At the first level, the positioning of chromosomes can be analyzed using FISH. 
While this technique does not inform directly on changes in gene expression, changes in chromosome 
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territory positioning occur reliably under repeated treatments and correlate to a change in cellular 
function and concomitant gene expression alteration. Several avenues have been pursued to 
understand and characterize chromosome territory positioning and organization, including the analysis 
of how sister chromatids ‘face’ each other during interphase (Sehgal et al., 2016). Also significantly, it 
was observed that the acrocentromeric chromosomes co-localize at the nucleolus where their Nucleolar 
Organizing Regions (NORs) organize and allow for the localized transcription of rRNA genes and 
subsequent ribosome biosynthesis. This example indicates that larger organization changes are 
functionally linked with highly controlled gene transcription.  
  To characterize the organization of the genome at the level of chromatin interactions and 
folding, several labs have employed the 3C technique or one of its variants (Barutcu et al., 2016; Dekker 
et al., 2002; Lando et al., 2018; Tolhuis et al., 2002). This technique probes interactions occurring 
between regions of chromatin and allows for the correlation of genome organization to gene expression 
at distinct and definable genomic loci. Specifically, it allows the examination of long-range interactions 
between two distinct genomic loci. For example, 3C can detect the interaction between a promoter and 
several putative enhancers regions, or an interaction occurring between two insulating CTCF sites. 
Additionally, 3C and its derivative techniques have been used to detect interactions occurring between 
active genes which are thought to be co-localizing during transcription, at sites suggested to be 
‘transcription factories’ (Carter et al., 2008; Eskiw et al., 2010; Eskiw et al., 2008; Osborne et al., 2004; 
Schoenfelder et al., 2010; Sutherland and Bickmore, 2009; Xu and Cook, 2008).  
 Transcription factories are accumulations (40-320nm in size) of RNA polymerase II (4-30 RNA Pol 
II per factory) (Eskiw and Fraser, 2011; Eskiw et al., 2008; Iborra et al., 1996; Rieder et al., 2012). It has 
been well documented  that there are distinct sites of transcription in the nucleus (Eskiw et al., 2008), 
containing active RNA Pol II as well as nascent RNA transcripts (Kimura et al., 2002). Contrary to the 
model of transcription whereby RNA Pol II locates to a gene to begin transcription, in the factory model 
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genes mobilize to these accumulations of RNA Pol II for transcription. It is worth noting that there are 
fewer of these distinct sites than genes being transcribed (Eskiw and Fraser, 2011). With fewer sites of 
transcription than genes expressed, seemingly genes must occupy the same factories – and not 
necessarily at random. Eskiw et al (2011) discovered ~60 transcription factories containing the Kruppel-
like factor (KLF)-1 transcription factor in erythroid cells. When accounting for the genes regulated by 
KLF1, they estimated 15-25 genes were being transcribed per factory, albeit transiently.  
  Another factor to consider about transcription factories is the increase in efficiency of 
transcription, brought about by concentrating or specializing the necessary elements at distinct nuclear 
locations. Localizing transcription machinery and appropriate genes increases the frequency and speed 
of transcription (Sutherland and Bickmore, 2009). Furthermore, it has been observed that genes loop 
out from their chromosome territory and towards a transcription factory (Branco and Pombo, 2006; 
Osborne et al., 2007), and additionally that like-regulated genes tend to co-localize at the same 
transcription factory (Eskiw and Fraser, 2011). Genes localized on different chromosomes have been 
found producing mRNA at a single shared location (Schoenfelder et al., 2010). Organization of this type 
occurring in the nucleus is not unfounded. The nucleolus performs an extremely similar act, wherein it 
gathers genes of related function (rRNA) to a distinct nuclear location at a site containing concentrated 
RNA Polymerase I. Interestingly, the nucleolus has been suggested to be a prototypical transcription 
factory (Carter et al., 2002; Cope et al., 2010; Kimura et al., 2002). From this evidence, it is clear that the 
nucleus is capable of organizing transcriptional events to specific locations. 
 
  The organization of genes around a transcription factory is permissive to long-range 
interactions, where genes contained at the factory are folded in a way that appropriate enhancers are 
brought into close proximity to gene promoters – awaiting transcription factor and protein mediator 
binding. Some have argued that regions of chromatin may be structurally folded and ‘poised’ prior to 
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recruitment to transcription factories containing transcription factors that bridge long-range 
interactions (Th2), while others subscribe that localization to a transcription factory and binding of 
transcription factors drives genome folding (Osborne et al., 2004; Spilianakis and Flavell, 2004; 
Spilianakis et al., 2005). It has been observed that a knockout of relevant transcription factors has 
caused organizational loss (Schoenfelder et al., 2010) and additionally that loss of transcription factors 
did not cause an organization loss (Spilianakis and Flavell, 2004).  This contradiction represents a 
complexity in genome organization, asking the question of exactly what drives organization. Many 
factors (transcription factors, localization to a factory, RNA Polymerase II, mediator proteins, enhancers 
and promoters) are involved in genome organization, and complete mechanisms have not been fully 
explained yet. For example, genes reliant on a trans-enhancer require localization between the 
promoter and the trans-enhancer. This interaction may be facilitated by localization of both elements to 
a transcription factory, where the promoter-enhancer interaction is stabilized by transcription factors 
located there. Conversely, the enhancer-promoter interaction may be formed by transcription factors 
prior to localization at a transcription factory. Interestingly, the mechanism of transcription by RNA 
Polymerase II is also still under investigation. 
  The idea of RNA Polymerase II transcribing DNA by processing along the strand has been 
challenged (Iborra et al., 1996). Evidence has recently emerged that DNA is instead reeled through 
polymerases (Papantonis et al., 2010) (Figure 1-7). Through FISH assays, Papantonis and Cook identified 
that two genes, Sterile Alpha Motif Domain Containing 4A (SAMD4a) and Tumor Necrosis Factor Alpha-
Induced Protein 2 (TNF-AIP2), were transcribed in the same location of the nucleus and were both 
regulated by Tumor Necrosis Factor  (TNF-α) responsive promoters. Both genes were known to be 
rapidly induced by TNF-α. To challenge the notion that RNA Pol II tracks along templates as transcription 
occurs, the interaction of TNFAIP2 to SAMD4a during transcription was traced using 3C. The TNFAIP2 
gene is 11 kb in size versus the much larger SAMD4a gene which is 221 kb and transcribes less than once 
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an hour upon induction. These genes reside 50 million base pairs apart on chromosome 14 and when 
not induced by TNF-α interactions between the two genes were not detectable. By tracing the 
interaction between the promoter of the TNF-AIP2 gene versus the different sites along the length of 
the SAMD4a gene, they were able to show that as increasing amounts of time passed following 
induction the TNFAIP2 promoter interacted further downstream of the SAMD4a promoter. This result 
suggested that the polymerases were immobile and were instead reeling the coding sequence of both 
genes through a shared transcription factory rather than tracing along the gene sequence (Papantonis et 
al., 2010). 
  Transcription factories display a level of gene and transcription factor specificity. To date several 
examples of like-regulated genes clustering at transcription factories have been observed. An example 
already mentioned includes the observation by Papantonis et al (2010)., wherein TNFAIP2 and SAMD4a, 
genes both regulated by NF-B (Nuclear Factor kappa-light-chain-enhancer of activated B cells), localize 
in a detectable and reproducible manner. Additionally, Osbourne et al (2007)., observed several 
immediate early (IE) genes co-localizing, also driving the rationale that the 3D organization of the 
genome during transcription was the cause of gene translocations between the MYC and IgH genes 
known to happen in Burkitt’s Lymphoma (Osborne et al., 2007).  
  From the pooling of this evidence, there is a strong argument for the existence of transcription 
factories, and that their function is to concentrate appropriate transcriptional machinery and factors. 
During transcription, like-regulated (similarly regulated genes) are accumulated at these factories for 
efficient transcription where necessary factors are concentrated. Furthermore, an evolutionary 
precedent is set for this by the cluster of acrocentromeric chromosomes at the nucleolus, organized 
specifically for the biosynthesis of ribosomes from the multiple rRNA genes of different chromosomes 
(Floutsakou et al., 2013; Pederson, 2011; Pontvianne et al., 2016). 
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Figure 1-7: Mobile or Immobile Polymerase Investigations using TNF- and SAMD4a. To understand 
whether RNA polymerases are mobile or immobile in the nucleus, Papantonis and Cook (2010)., 
investigated the interactions occurring between two genes known to be transcribed at the same time 
and in proximity to each other. By measuring the possible interactions occurring between these two 
genes, Sterile Alpha Motif Domain Containing 4A (SAMD4a) and Tumor Necrosis Factor Alpha-Induced 
Protein 2 (TNF-AIP2), following activation of transcription by TNF-α. By tracing the transcription of the 
long SAMD4a gene (221 kb) using the nearby, quick and repeated transcription of TNFAIP2 (11 kb), 
Papantonis and Cook (2010)., provided evidence that RNA Polymerase II was immobile and suggested 
DNA was ‘reeled’ through.  
 
1.7.1 Organization of the -globin Locus 
The investigations into -globin locus represent one of the earliest examples of genome 
 organization in a mammalian genome (Carter et al., 2002; Tolhuis et al., 2002). In their paper, Tolhuis et 
al (2002)., investigated the interaction between DNAse hypersensitivity sites (exposed DNA that are 
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digestible by DNAse I) occurring in the locus control region (LCR) and the head-to-tail cluster of globin 
genes in the globin locus. Resultantly, they discovered which sites of DNAse hypersensitivity (HS) had 
higher levels of interaction with the active globin gene, and observed a lack of interaction between 
these sites and the non-expressed globin genes in erythroid cells. It was also observed that the locus did 
not form long-range interactions to promote globin expression in cells that do not express these globin 
genes. These experiments displayed  ‘looping out’ of inactive globin genes. They also demonstrated the 
preferential and detectable long-range interactions between distinct HS elements of the LCR and active 
globin genes. Furthermore, it was shown that topological organization is cell-type dependent, as the 
non-expressing brain cells had shown no significant long-range interactions in these instances. 
 
  These early investigations into the globin locus quickly expanded into other questions of 
topology, such as the function of CTCF in the globin locus (Splinter et al., 2006). CTCF insulates regions of 
the genome and prevents atypical interactions between enhancers and promoters. In the investigations 
by Splinter et al (2006)., CTCF binding sites were identified and were known to contact each other prior 
to globin expression in erythroid progenitor cells. It was discovered in the course of these experiments 
that a homozygous knockout of the CTCF protein in mice was embryonic lethal, displaying the 
significance of this protein, and a mutation of the CTCF binding sites resulted in a loss in long-range 
interactions between CTCF sites and of the regulatory interactions of the globin genes to the LCR. The 
authors suggest that CTCF is essential for establishing early organization of the locus, however that it is 
not essential as differentiation progresses. Further investigations into this region have highlighted 
specific histone modifications at the LCR, when interactions are formed between the globin locus and 
loci on other chromosomes (Miles et al., 2007). As inter-chromosomal interactions require 
spatiotemporal organization of chromatin, these investigations highlight the role of genome 
organization for gene expression (Pink et al., 2010). Overall the investigations into the globin locus 
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highlighted several aspects of genome organization, including the identification of specific regulatory 
elements in the LCR and the capacity of the genome to utilize the same enhancer on different genes as 
development progresses. 
 
 
Figure 1-8: Organization of the β-globin locus in mice. Schematic illustrating the β-globin locus 
contained on chromosome 7 in mice. The expression of the contained globin genes is regulated by a 
nearby Locus Control Region (LCR). As development progresses the appropriate globin gene interacts 
with the HS2 site inside of the LCR to promote gene expression. Earlier genes are looped away from the 
LCR when no longer being transcribed and later expressing genes become bound to the LCR.  
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1.7.2 H Enhancer/ODR 
 Olfaction is a vital process for many eukaryotic species. The versatility in sense of smell stems 
from a genomic organization process, wherein the H enhancer selects from one of many Odorant 
Receptor (OR) genes to express as the olfactory neurons develop (Lomvardas et al., 2006). In mice, this 
requires the H enhancer (chromosome 14) to operate in trans to activate odorant receptor genes (1300 
genes) located on other chromosomes, bypassing the odorant genes located downstream of itself. Upon 
selection of odorant gene, the second allele of the H enhancer is methylated and prevented from 
forming interactions with odorant genes. These observations that an enhancer can act in trans suggests 
that a level of chromosome territory organization must occur to be permissive for such interactions, and 
additionally that enhancers do not necessarily regulate nearby genes, but rather have the ability to 
bypass local genes to regulate genes on other chromosomes (Savarese and Grosschedl, 2006).  
 
1.7.3 V(D)J Recombination 
 Variable (V), Diversity (D), and Joining (J) recombination requires genomic organization to 
successfully occur. During V(D)J recombination, T Cells and B Cells undergo somatic recombination to 
create a novel gene from coding sequences at different loci that they and their daughter progeny will 
express. The process of V(D)J recombination is sophisticated and requires precise three-dimensional 
organization of its genetic components to successfully occur, wherein distally located coding sequences 
are brought into close proximity and recombined into a novel product. Each of these genes (VDJ) 
contains a Recombination Signal Sequence (RSS) up-stream and downstream of the coding sequence 
that orchestrates several enzymes, notably Recombinase Activating Genes 1 and 2 (RAG1/2), to target 
the strand for nicking and subsequent recombination. Several labs have ascribed the CTCF sites in these 
regions as key parts of recombination process, due to their ability to organize the region by forming 
chromatin loops (Chaumeil and Skok, 2012; Frock et al., 2015; Guo et al., 2011; Jung et al., 2006; Lin et 
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al., 2015). Vitally, transcription is required for V(D)J recombination to occur. When transcription was 
inhibited this recombination did not occur (Bolland et al., 2007). As V(D)J recombination provides the 
ability for an adaptive immune system, it represents a significant example of how genome organization 
translates into a larger function.  
 
1.8 Topologically Associating Domains 
1.8.1 Overview  
  Topologically associating domains (TADs) represent a level of organization of the genome. These 
regions consist of sections of chromatin roughly 100 kb to 1 Mb in size. TADs cover a considerable 
portion of the mammalian genome and are estimated at 91% coverage in the mouse genome (Dixon et 
al., 2012). The borders of a TAD are defined by CTCF binding sites and housekeeping genes, as well as 
other elements, that isolate internal elements (enhancers, genes) from interacting with external 
features while simultaneously promoting internal interactions.  
  TADs are a conserved element of mammalian genomes and similar topological patterns have 
been observed between the HoxA (homeobox A cluster) locus in both mice and humans (Dixon et al., 
2012). There is a high conservation of TAD boundary marks for when comparing differentiated tissues of 
the same species, as well as comparing between humans and mice. Conservation of such a feature 
indicates the importance of TADs and their role in gene regulation, as well as the organization of the 
genome on a whole.  
  The function of compartmentalization provided by TADs allows internal elements to operate 
independently of the local environment. Boundary elements of TADs have been ascribed roles in 
stopping the spread of heterochromatin (as reviewed by (Burgess-Beusse et al., 2002)). It has been 
observed that TADs are able to maintain distinct chromatin environments (euchromatin or 
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heterochromatin) from their neighbors (Pope et al., 2014). For example, a euchromatinized TAD may be 
positioned between two heretochromatinzed TADs. This chromatin state, which is maintained 
separately from TADs neighbours, delineates TADs as functional units of the genome with an 
independent and maintained environment. 
  Compartmentalization of TADs also provides roles during DNA repair. During double-stand break 
(DSB) repair, the histone variant responsible for marking damaged strands, H2AX, marks the TAD from 
the damaged site and up to the boundaries (Aymard et al., 2017; Marnef and Legube, 2017). In this 
‘intra-TAD model’, H2AX integrates bidirectionally from the induced damage until reaching the TAD 
boundary. Following this marking by H2AX, the DSBs co-localize to distinct sites of the nucleus for 
repair. Alternatively, unrepairable DSBs may be localized to the periphery of the nucleus. The precision 
of H2AX integration further demonstrates the existence of TADs in the genome, as well as providing a 
specific example of a function not possible without their presence. 
  A growth issue in mice has been directly linked to aberrancies in TAD boundaries, observed in a 
boundary element deletion resulting in malformed digits (as reviewed in (Lupianez et al., 2015)). F-
syndrome, the fusing of the index finger and thumb in humans, was attributed as the result of an 
inversion of a boundary element flanked by several enhancers – causing enhancers to act abnormally on 
another developmental gene Wnt6 (Wingless-type MMTV integration site family, member 6) located in 
the neighboring TAD (Lupianez et al., 2015). Additionally, in humans, the deletion of a TAD boundary 
element results in nearby enhancers acting abnormally upon the Lamin B1 (LMNB1) gene, inducing 
adult-onset-demyelinating leukemia (Giorgio et al., 2015). These examples display the importance of 
maintaining TAD structure and the controls TADs convey on compartmentalizing long-range interactions 
that (along with transcription factors) regulate gene expression. 
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Figure 1-9: Topologically Associated Domains. Schematic of the organization of three TADs containing 
several features. TADs compartmentalize regions of the genome and facilitate internal interactions while 
blocking external interactions. TAD boundaries stop the spread of heterochromatin and maintain 
chromatin states unique from neighboring TADs.  
 
1.8.2 LADS, MADS, and NADs 
  Several other forms of domains exist, namely Lamina Associated Domains (LADs) sometimes 
also called Matrix Associated Domains (MADs), and Nucleolar Associated Domains (NADs). LADs are 
regions of the genome with low gene density and activity, spanning 10 kbp to 10 Mbp in size, that locate 
to the nuclear periphery and tether at the nuclear matrix (van Steensel and Belmont, 2017). By tethering 
chromosomes at the periphery of the nucleus, it is thought that LADs contribute to chromosome 
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topology and gene expression by providing an anchor point. A weakening of this binding caused by 
hypomethylation of a LAD has been observed in colon cancer (van Steensel and Belmont, 2017) – 
potentiating altered chromosome topology and subsequent mis-regulation of genes through a loss of an 
organizational element. NADs are regions of heterochromatin containing inactive genes as well as the 
rRNA genes that associate with the nucleolus (Pontvianne et al., 2016). LADs and NADs are further 
examples of genetically programed elements of nuclear organization and further signals that the 
organization of the genome is an important and conserved process. 
 
1.9  Summary 
 RNA-Seq performed on proliferative, quiescent, and Rapamycin treated 2DD cells in our lab 
revealed a region of chromosome 4 containing several up-regulated genes at the 74 MB to 76 MB loci. 
As these growth conditions affect gene expression profiles, a question remained as to how the 
organization of the genome alters in these conditions, especially the up-regulation of the cluster of 
chemokine genes on chromosome 4, region 74 Mbp. Previous work in the Eskiw lab has displayed 
altered genome organization at the level of chromosome territories in these conditions. However, a 
deeper (gene-interaction) analysis has yet to be performed to show if alterations to organization are 
occurring at sub-chromosomal levels and are responsible to changes in gene expression profiles.  
The question is also raised for if chromosomal repositioning alters or facilitates sub-chromosomal 
organization, during our treatment conditions. To accomplish this level of analysis the technique 3C is 
necessary; however, its use has yet to be established in the Eskiw lab. To expand the capabilities of the 
Eskiw lab as well as investigate the region of interest on chromosome 4 and other potential targets this 
project will seek to employ and improve the 3C technique in accompaniment with traditional fluoresce 
in situ hybridization (FISH) microscopy to characterize changes in genome organization induced by 
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Rapamycin treatment. 
 
1.10  Hypothesis 
 Based on the observations of the Eskiw laboratory and those from the literature, I hypothesize 
that changes in growth conditions, moving from proliferative growth to quiescence or under conditions 
of Rapamycin treatment, will result genome re-organization. Specifically, I hypothesize that 
chromosome 4, which contains a cluster of chemokines genes that dramatically change expression in 
response to Rapamycin, will change position within the nuclear volume. I further hypothesize that 
specific sub-regions of chromosome will undergo re-folding in response to these transcriptional changes 
resulting in new long range chromatin interaction forming and the disruption of others.  
 
1.11  Objectives 
To confirm these hypotheses, the following objectives were planned: 
 
 
1) Identification of reliable internal controls for 3C.  
2) To confirm that chromosomes are reorganizing and; therefore, there is a change in genome folding 
using chromosome painting by DNA FISH 
3) Confirmation of a specific interaction computationally theorized to occur from RNA-Seq datasets, 
specifically a dataset found on Chromosome 4, region 74 Mb. 
4) To utilize an optimized 3C protocol to identify specific changes in long range chromatin interactions 
occurring at other locations in the genome, in divergent growth conditions. 
5) Perform Hi-C to model 3D spatial conformations in collaboration with Dr. Anthony Kusalik. 
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2.0 Materials and Methods 
2.1 Cell Culture, Cell Counting 
Cell Lines 
  Three cell lines were used in all outlined experiments and all were resuspended prior to 
reaching 70% confluency. Primary human foreskin fibroblasts (designated 2DD) were used during FISH 
and 3C experiments and were harvested between passage 14 and passage 17, with a confluency no 
greater than 70% (Bridger et al., 1993). NB1 hTERT were derived from a parental line (human 
fibroblasts) and immortalized by expression of human telomerase (Mehta et al., 2010). Human Umbilical 
Vein Endothelial Cells (HUVECs) (Lonza, USA, Cat #: CC-2517) were harvested between passage 4 and 
passage 7 and at a confluency no greater than 70%. NB1 hTERT and HUVEC lines were used in the initial 
optimization of the 3C protocol. 
 
Cell Culture 
  NB1 hTERT and 2DD cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
containing 4.5 g/L glucose, L-glutamine & sodium pyruvate (Corning, USA, Ref: 10-013-CV) 
supplemented with 10% fetal bovine serum (FBS) (Gibco, Thermo Fisher Scientific, USA, Ref: 12483-020) 
and 1% penicillin-streptomycin (Hyclone, GE Healthcare Life Sciences USA, Ref: SH40003.01). HUVECs 
were cultured in EGM-2 SingleQuots (Lonza, USA, Ref: CC-4176) containing the full supplements 
provided and 1% penicillin-streptomycin. Cultured cells were resuspended prior to reaching 70% 
confluency using TrypLETM Express (Gibco, Life Technologies, USA, Ref: 12604-021). Cell counts were 
performed by hemocytometer and passaged cells were seeded at a density of 3000 cells/cm2 (225,000 
cells per T75 flask, 550,000 per 15 cm tissue culture plate). For FISH assays, cells were cultured in 6-well 
dishes containing 22mm X 22mm glass coverslips and removed with forceps prior to experimental 
processing.  
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Cell Treatments 
  Cultured cells were induced into quiescence by serum deprivation (0.5% FBS) in culture media. 
Rapamycin treatments occurred in standard culture media (DMEM, 10% FBS, 1% penicillin-
streptomycin) at a concentration of 500 nM Rapamycin (Fischer BioReagents, Israel, Code: BP2963-1). 
Rapamycin was dissolved in DMSO (Fisher Chemical, USA, D128-4). Final Concentration of DMSO during 
Rapamycin treatment was less than 0.001%. Cell treatments occurred for 5 days, with media 
refreshment on the third day, prior to harvesting. Prior to harvesting for 3C, HUVECs were treated with 
10 ng/ml Tumor Necrosis Factor- α (TNF-α) (Abcam, USA, Ref: ab9642) for 30 minutes. 
 
2.2 Electrophoresis 
2.2.1  Agarose Gels 
  To verify PCR products, a 2% agarose gel  (Melford, USA, cat #: MB1202) 1x TAE (40 mM Tris, 20 
mM acetic acid, 1 mM EDTA)) (Tris-Base: Fisher, USA, Cat #: BP154-1; EDTA: Boehringer Mannheim 
GmbH, Germany, Cat #: 808-288) containing ethidium bromide (Sigma Aldrich, USA, Cat #: E1510-10ML) 
was used. For evaluating the digestion and ligation of 3C samples a 1% agarose gel was used. Samples 
were diluted in 6X Orange G DNA loading buffer (Sigma Aldrich, USA, Cat #: 1936-15-8) and separated in 
1x Tris-Acetate-EDTA (TAE) buffer at 100 volts (constant) for 30 minutes. 3C library digestion efficiency 
was analyzed by separating samples on a 1% agarose gel with otherwise identical conditions. Agarose 
gels were visualized on a Benchtop UV Transilluminator BioDoc-ItTM Imaging System. 
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2.2.2 Tris-Borate Gels 
  To verify the size of PCR products (50-250 base pairs) a 6% Tris-Borate-EDTA (TBE) (6% Bis-
acrylamide, 0.1% Ammonium persulfate (Fisher, USA, Cat #: BP179-25, 0.01% TEMED, 0.5x TBE buffer) 
gel was separated at 200 volts (constant) for 20-25 minutes in TBE buffer (1x TBE 100 µM Tris-Base, 100 
µM Boric Acid (EMD, USA, B10058), 1 µM EDTA). Samples were diluted with 10X TBE loading buffer (45 
µM Tris-base, 45 µM Boric Acid, 50% glycerol (Fisher Chemical, USA, cat #: G33-1), 3.5 µM bromophenol 
blue (Fisher Biotech, USA, cat #: BP115-50), 4.5 µM xylene cyanol FF) (Sigma Aldritch, USA, Cat #:2650-
17-1) prior to being separated. Following separation gels were immersed in water containing 0.001 M 
ethidium bromide for 10 minutes before being visualized on a Benchtop UV Transilluminator BioDoc-ItTM 
Imaging System. 
2.2.3 Sodium Borate Gels 
  To verify the size of PCR products (50-250 base pairs) a 6% Sodium-Borate (SB) (6% Bis-
acrylamide, 0.1% Ammonium persulfate, 0.01% TEMED, 1x SB buffer) gel was separated at 250 volts 
(constant) for 12-16 minutes in 1x SB buffer. Samples were diluted with 10x TBE loading buffer (45 µM 
Tris-base, 45 µM Boric Acid, 50% glycerol (Fisher Chemical, USA, Cat #: G33-1), 3.5 µM bromophenol 
blue (Fisher Biotech, USA, Cat #: BP115-50), 4.5 µM xylene cyanol FF) prior to being separated. Following 
separation, gels were immersed in water containing 0.001 µM Ethidium Bromide for 10 minutes before 
being visualized on a Benchtop UV Transilluminator BioDoc-ItTM Imaging System. 
 
2.3 DNA Fluorescence in situ hybridization and Erosion Analysis 
Fluorescence in situ Hybridization 
  Cultured cells were grown directly on glass coverslips, and washed with PBS, prior to fixation 
with ice-cold 3:1 (v/v) methanol-acetic acid (Methanol; BDH, Germany, cat #: BD1135-4LP, Acetic acid; 
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Fisher Chemical, USA, cat #: BP2401-212). Cells were then incubated for an hour at 4oC, and washed five 
times with 3:1 (v/v) methanol: acetic acid. Fixed cells were dried at 70oC for an hour, prior to a 
dehydration series of 5-minute ethanol washes (in order: 70%, 90%, 100% ethanol). Cells were then 
incubated at 70oC to complete the drying process. DNA of fixed cells was denatured by treating with 
70% formamide (Alfa Aesar, USA, Cat #: A11076), and 2X saline sodium citrate (SSC) (Fisher, USA, Cat #: 
BP1325) for 2 minutes at 70oC. Cell then underwent a second dehydration series in ice-cold ethanol.  
Chromosome-specific DNA probes were generated in-house by amplifying chromosome specific 
sequences from flow-sorted chromosomes using degenerative oligonucleotide primers. In result, 300-
500 nt (chromosome-specific) templates were generated by PCR with biotinylated-uracil residues 
incorporated for fluorescent signal amplification. For each coverslip to be labelled, 200-400ng of 
chromosome-specific DNA probes were ethanol precipitated with 3.5g and 3g herring sperm DNA and 
resuspended in 12.5 l hybridization buffer (50% formamide, 4X SSC, 50mM sodium phosphate and 20% 
(w/v) dextran sulfate). Probes were denatured at 90oC for 30 min and renatured by incubation at 37oC 
for 20 mins before being added to fixed coverslips. Coverslips were sealed onto glass slides using rubber 
cement and incubated for 2 minutes at 60oC, prior to being placed in a humidity chamber for 12 hours at 
37oC. Coverslips were then removed from glass slides while being washed in 50% formamide, 2X SSC pH 
7.0, at 45oC. Coverslips were then washed several times with 0.5X SSC pH 7.0 at 60oC, then stored in PBS 
at room temperature. Directly labeled probes (Chromosome 4: Cytocell Aquarius, USA, cat #: LPP04G) 
were then mounted in Hoechst 33342 (Invitrogen, USA, Cat #: h3570). Coverslips with biotinylated 
probes were incubated with antibodies at room temperature for an hour, before being washed with 
0.05% Triton X-100.The order of antibody addition was as follows: Streptavidin Cy3 (1:200; Vector 
laboratories, USA, cat #: Ba-0500), goat anti-rabbit biotin (1:200; Cedarlane, UK, Cat #: 111-065-003), 
Streptavidin Cy3. After treatment with antibodies, coverslips were washed with PBS and mounted in 
Hoechst 3342. 
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Fluorescence in situ Hybridization Image Capture and Image Processing 
  Images of nuclei were captured using a Nikon Y-IDP with an X-Cite fluorescence light source and 
a Nikon Digital Sight DS-U3 camera. Nuclei images were collected using three channels; Red - DOP 
Probes (Chromosomes X, 10, 18), Green - Direct-labelled probes (Chromosome 4), and Blue (Hoescht 
33342). Resulting images were overlaid together using Adobe Photoshop (CS6) for use in Erosion 
Analysis.  
 
Fluorescence in situ Hybridization - Erosion Analysis 
  Using Cell Image Analyzer software, images of nuclei were divided into five concentric rings of 
equal area, numbered one (periphery) to five (most internal) and the signal from each chromosome was 
measured and standardized to the Hoechst 33342 signal (stains DNA). The resulting data was plotted in 
bar graphs depicting standardized chromosome signal intensity per concentric ring or ‘shell’. Signal 
intensity of each chromosome was normalized to the quantified background DNA in each shell as 
detected by Hoechst 33342. The resulting data were tested using a 2-tailed Student’s T-test with 
unequal variance (Microsoft Excel) to demonstrate significance in the repositioning of chromosomes. 
 
2.4 Chromosome Conformation Capture 
  Five-million cells were harvested for each replicate of 3C (Figure 2-1: A), for each treatment 
condition. Cultured cells were harvested as follows: proliferative cells were harvested upon reaching 
70% confluency, quiescent induced cells were harvested after 5 days of treatment with culture media 
containing only 0.5% FBS, Rapamycin treated cells were harvested after 5 days of treatment with 500 
nM Rapamycin. Culture media was changed every 2-3 days to ensure that rapamycin was not depleted. 
Cells were suspended and fixed with 1% formaldehyde (Electron Microscopy Sciences, USA, Cat #: 
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15714) for 10 minutes at 37°C to capture three-dimensional chromatin contacts. Fixation was quenched 
with 2.0 M glycine (Fischer BioReagents, USA, Cat #: BP381-5) to a final glycine concentration of 125 mM 
and incubated at room temperature for 10 minutes. Cells were then washed in PBS to remove excess 
glycine. Cells were lysed for 10 mins at 65oC, in a solution containing 10 mM NaCl, 10 mM Tris-HCl pH 
8.0, 1 mM EDTA, 1% SDS containing 1 X protease inhibitor cocktail. Following this incubation cells were 
chilled on ice for 5 min, before being diluted with a 1X HindIII restriction enzyme buffer (NEB Buffer 2.1). 
Samples were digested using 600 U of HindIII (NEB, USA, cat #: R0104M) in 1X 2.1 NEB Buffer (500 µl 
total volume) overnight at 37°C, 950 RPM. HindIII was heat inactivated by incubating samples at 80°C for 
20 minutes. Samples were ligated with 1600 U of T4 DNA Ligase (NEB, USA, cat #: M2020L) in 1X T4 DNA 
Ligase buffer (1.0 ml) for four hours at 16°C, 950 RPM. Following ligation, samples were incubated 
overnight at 65°C with proteinase K (Invitrogen, USA, 100053) to remove cross-linked proteins. Samples 
were then treated with RNAse A for 1 hour at 37°C. Samples were extracted by equal volumes of 1:1 
phenol:chloroform and 19:1 chloroform:isoamyl to remove proteins. DNA was precipitated using 1 l 
glycogen (20 mg/ml – Roche. Cat #: 10-901-393-001), 10% volume NaOAc (Fisher chemical, USA, cat #: 
S208) and equal volume of isopropanol, and incubated for 20 minutes on ice. Following centrifugation, 
the resulting pellet was washed with 70% ethanol and air dried until resuspended in Tris-EDTA (TE) 
buffer (10 mM Tris-HCL pH 8.0, 0.1 mM EDTA).  
  Initial success of 3C assays were tested in the HUVECs (Figure 2-1: B) cell line recapitulating 
earlier work by Papantonis and Cook (Papantonis et al., 2010), wherein an interaction between TNFAIP  
and SAMD4a was detected by 3C. HUVEC cells were either untreated (Pro) or treated with TNF-α (10 
ng/ml) for 30 mins (TNFα #1 and TNFα #2) prior to collection of cells.  
  To analyze the digestion and ligation quality of a 3C library, each sample is separated on a 0.8%-
1.0% Agarose gel (Figure 2-2). For each library a digestion efficiency (DE) and 3C library (3C) are 
separated and analyzed for adequate digestion in the DE sample, and adequate ligation in the 3C 
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sample. Adequate digestion is observed as a smear on the gel below the 10 kB shear limit of DNA. 
Adequate ligation of 3C libraries is observed in the formation of a ‘3C band’ – a band occurring at a 
slighter higher height than the DNA shear limit band. 3C data was generated by qPCR amplification of 
primer pairs that capture potential interactions. The resulting data was analyzed for significance by 2-
tailed Student’s T-tests with unequal variance (Microsoft Excel). 
 
 
Figure 2-1: Chromosome Conformation Capture and Initial 3C assays in HUVECs. (A) Schematic of the 
3C assay. Cells are fixed in formaldehyde prior to isolation of nuclei. Samples are then permeabilized and 
chromatin is digested using a restriction enzyme. Following digestion, ligation using T4 DNA ligase is 
performed in a large volume to favor intramolecular interactions. Resulting ligated products are purified 
and used in qPCR. (B) Initial 3C assays recapitulating interactions between TNFAIP and SAMD4a 
observed in earlier work by Papantonis and Cook (2010). HUVECs were either untreated (Pro) or treated 
with 10 ng/ml TNFα 30 mins prior to harvest. TNFAIP Anchor 5’ and SAMD4a Anchor 5’ detects an 
interaction occurring between the promoters of both (TNFAIP2 and SAMD4a) genes. TNFAIP Anchor 3’ 
and SAMD4a 3’ detects an interaction occurring between the promoter of TNFAIP2 and a region 
downstream of the promoter of SAMD4a. (Pro = Proliferative cells, TNFα #1 and TNFα #2 = Cells treated 
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with 10 ng/ml TNFα) 
 
 
 
Figure 2-2: Analysis of 3C Digestion and Ligation. 3C samples were separated by electrophoresis and 
visualized using a 1.0% agarose gel by staining with ethidium bromide. Samples collected after digestion 
with HindIII were marked as ‘Digestion’ and completed 3C libraries are marked as ‘3C Library’. Digestion 
samples of good quality display a smear of DNA along the length of the agarose gel. Good quality 3C 
libraries display a concise band that separates at similar height to a 10,000 bp marker.  
 
2.5 PCR and Synthetic Libraries 
  Synthetic libraries were generated to test the ability of 3C to detect products without 
preforming the entire protocol (Figure 2-3). Primer pairs for HindIII cut sites of interest were used to 
amplify genomic fragments using standard PCR reaction conditions (300 nM primers, 0.025 U/µl Taq 
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polymerase, 2 mM MgCl2, 0.2 mM of each dNTP, 50 ng/reaction genomic DNA) using 35 cycles of 95oC, 
60oC and 72oC (PCR Mix; Thermo Scientific, USA, cat #: K0171). The appropriate primer pairs (matching 
the genomic location of interest) were used and equal volumes of reaction products were combined into 
a pooled volume. This mixture was digested with 500 U of HindIII enzyme for 2 hours at 37oC. Following 
digestion HindIII was heat inactivated by incubating at 65oC for 10 minutes. The resulting digested DNA 
was diluted into a solution containing a 1X buffer of T4 DNA ligase buffer and 400 U of T4 DNA Ligase. 
Samples were incubated at 16oC for 4 hours. Reaction mixtures were purified by phenol:chloroform:IAA 
extraction and precipitated using 10% volume NaOAc and 2.5x volume of ethanol and incubated for 2 
hours at -20oC. To test if we could detect putative interactions, 10 ng of template were used in PCR 
reactions to determine if primers from different pairs (paralleling combinations used in 3C) could 
amplify products. 
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Figure 2-3: Construction of Synthetic Libraries. To confirm if desired 3C products could be produced by 
qPCR, a synthetic library was produced using PCR to amplify genomic regions for targets of interest 
(CXCL locus, chromosome 4). A 1 kB DNA ladder (Invitrogen, USA, Cat #: 10488090) was used for 
comparison. Amplified genomic regions were digested using HindIII, prior to ligation with T4 DNA ligase. 
This digestion and ligated yielded a synthetic library containing possible 3C products. The synthetic 
library was then tested against combinations of primers used for 3C for the CXCL locus on chromosome 
4. Resulting PCR products were separated on a 1% agarose gel and sized. Correct product formation was 
evaluated by the resulting size of products by comparing expected and observed sizes. 
 
2.6 Quantitative PCR 
 qPCR reactions were performed in triplicate on the Rotor-Gene Q (Qiagen) qPCR machine using 
SYBR® Select Master Mix (Applied Biosystems, USA, Ref: 4472908), template DNA, and 300 nM of both 
forward and reverse primers in 10 µl reactions. Reactions occurred for 40 cycles under the following 
profile conditions: 95oC for 5 minutes, 95oC for 20 seconds followed by 60oC for 30 second (repeated for 
40 cycles), then held at 50oC for 30 seconds prior to Melt Analysis by the software. Results were 
analyzed using the Rotor Gene Q series software. PCR products were analyzed by melt peaks produced 
by the software and size identification by separation on a 6% Tris-Borate-EDTA (TBE) or 2% Agarose gel. 
Following slope correction CT values of products were measured using a standardized threshold of 0.01, 
ignoring the first 15 cycles. 
 
2.7 3C Primer Design 
  In designing of 3C experiments primer pairs were chosen that annealed upstream (5’) of a 
restriction site and downstream (3’) of the restriction site. In Table 2-1 below these are referred to as 
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forward (5’) and reverse (3’). Downstream (3’ or reverse) primers capture the restriction fragment of 
interest that is used to detect occurrence of interactions. Primers designed against EFEMP2 were 
utilized to quantify the DNA and normalize loading of 3C library during qPCR assays. 
Primer Name Forward Reverse 
CXCL8 TTTGGACTTAGACTTTATGCCTGAC ACCCAGTTTTCCTTGGGGTC 
Range Finding Site 1 GCCACAAAGACATCCTTAGAATTTAG ATTCTGACAAATTGAACATATGCC 
Range Finding Site 2 GAGCTTCTGGAACCTTACAACC GGGGGCAAGTACAGCTAATAGTC 
Range Finding Site 3 CAAAAGGCTGTCTAAGGCAGAG  TACTGGCAGGGGCAAACT  
CXCL6 CTTCTTTCCACACTGCCCCC CCGACTGGCAGGAAACTCAA 
CXCL1 CACACTCAAGAATGGGCGGA GGGGCACATGCCAGTATTTC 
CXCL3 CCTAGAAAGCTGCTGTTCTCTT TCCAAGCAACTTCAGAGTGAC  
CXCL2 GAAGACTTCTCCTAAGTGATGCTC  GCACCCATTTTCTCATTACAG  
EREG_1 ACGCACCCTAGGCCAATAAG ACCTACCGTGGGGGATAATG 
EREG_2 TTTCCTGAGCTAAATGCTTCATTG TCTTGAGCTATGACCTGGGA 
AREG TGACAAGGCGTGTCTTCTTGA ACGTGCGGTGTGTTTTAAGC 
GAPDH P AGGGTGCAGCTGAGCTAGG AACACCCCCAGTCATACGAA 
GAPDH E TGTTTGCCAATCTCCTTGTTT TCTCTGCTGCATGAAACTGG 
LIF Anchor 1 CGCTCCCTGCAGCAGGACAA TACCCCTGGGATACTGACAGGAGA 
LIF Anchor 2 GCCCTACCCACCTCCACAAA AGGAGGTCACTTGGCATTCAGG 
LIF Downstream Site 4 CCGGACTTTCCCCGGTTTT GTGGGCAGTGAGGGAAGTGAG 
LIF Downstream Site 3 AGCCATAGCATGGGCTGGC CCTTGGGATGGGGTTTTACATATGGGATA 
LIF Downstream Site 2 CCCACCTCATGGCATTTGCAGA CACAGGCACAAACTGGGGCT 
LIF Downstream Site 1 ACCCAGGACTTAGCTGTCATTCTCT AGTCTCCAGGAGGCTGGCTC 
LIF Upstream Site 1 GATGTGCCCATGTCCCCCA TGGATGTCAGTGTCCTAATGGAGGC 
LIF Upstream Site 2 CCCAGTAGTATGTGGACTAGTGGCC CCCGGCCCCAAAGAACCTTTT 
LIF Upstream Site 3 GCCTGGTGGCATTGAAACTTCC CCACTGCAGGCCTTAGTTTCCC 
LIF Upstream Site 4 CTTTTGGCTCAGCCACTGCTGG CCTGGTATGGGAGAATTGTATGGCCTC 
LIF Upstream Site 5 GGAGACTGCAAAAAGACCCCAGG CCCCTTTCTCAGCCTAGCTACTTCC 
LIF Upstream Site 6 TCATCAGTGATGGTCATTCGCGTG TGCTAAGAGATTACAAGACATGTTGCAACCA 
KRTAP1-1 GCATCAGCAAAAATAGACAAGTG  TCACTCAGTTTAGTGTTTTATTGGC  
KRTAP1-5 GGTTTGATTTCCTCATCTACAAAG GAACCATCCTACCCACCTCC  
KRTAP2-1 GGCAATATCTTCCTGATTAGTTTCT  TTGTATGCTTTGAATACTAGCCAAC  
KRTAP2-3 AAATTAAAAAGACTAAAGACCCCTG  CCTAGCATGTGATAGAAAAGAGATTTC  
KRTAP2-4 GTCAGTTTACTACCAGTGGTCATTC  CCTTATCCATAGAAATCTCATCTATTCA  
KRTAP4-12 CCAAGGTTAAAGAGAAAGTAAGCC  GAATAAATGCCATAGCGCAA  
KRTAP4-6 TCTATCAGTTACTTTGTCACAACTGG  GGTCACTTGAAAAAGTAAAGGACAC  
KRTAP3-1 CATTCTGTTAATCTCTAGACTCTAGCATAG  GCTCTCATAGTGGAATTTATCGAA  
KRTAP4-11 GATTTGAATCAAGATGGAATGC  CTTTCTCCCTGTTCTCTCTTTGT  
KRTAP4-4 GCTTATCAAATCCAAGAGTTTTTTG  CTAGGAAATACTCTTCTAGACCTTGATCTA  
KRTAP4-5 GAGTCTTACTAGGTTTGTTGAGTTTCC  CCAGAAAGGCAACAATAGATGCCTGTTTTG  
KRTAP4-7 GGGTTTTGACAAATGAGTAGGAG  CAAAATGCTTGTCCAAGATTAAAG  
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Table 2-1: 3C Primers. Primers designed for use in Chromosome Conformation Capture Assays (3C). For 
the detection of interactions only reverse primers were used. For construction of the synthetic libraries 
to both 5’ and 3’ primers were used in amplifying the initial genomic fragments prior to digestion and 
ligation, where final products were detected by combinations of 3’ primers. All primers are given in the 
5’-3’ direction.  
 
2.8 3C Controls 
  To quantitatively measure the efficiency of library formation, an interaction between two 
neighboring restriction fragments was detected and used to normalize 3C data. Neighbouring restriction 
fragments ligate together at high frequency, due to their immediate linear proximity and likelihood of 
being cross-linked during fixation with formaldehyde. An interaction between two neighboring 
restriction fragments at the LIF gene (known as LIF A1xA2) was measured by qPCR and used to 
normalize data collected. Alternately, another set of primers was designed to detect an interaction 
between neighbouring restriction fragments occurring at the Glyceradeldehyde 3-phosphate 
dehydrogenase (GAPDH) gene. These control interactions measure an ‘inversion’ in the linear sequence 
of DNA, and can only be detected in samples that have successfully undergone both digestion (by 
HindIII) and ligation (by T4 DNA ligase) to create a 3C library.  
   Linear distance from the anchor fragment plays a significant role in interaction strength at close 
distances (<25,000 bp genomic distance). To ensure our libraries were performing adequately, a set of 
‘Range-finding site’ (RFS) primers were designed at sites near the CXCL8 gene on chromosome 4. These 
primers captured restriction fragments occurring at distances of ~5000, ~15,000, and ~25,000 bp away 
from the CXCL8 gene. Using qPCR, we amplified the library using combinations of the CXCL8 anchor 
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primer and these RFS primers. We observed declining interaction frequencies as a result of increased 
distance and concluded our 3C libraries we’re performing in a predictable and appropriate manner. 
 
2.9 Graphing of 3C Data 
From Ct to Relative Value 
  Cycle threshold (Ct) values are standardized by alignment of a neighboring interaction at the LIF 
gene (LIF A1xA2). This novel ligation product is formed by the inversion of one of the restriction 
fragments of the neighboring pair and is used to estimate the efficiency of 3C library synthesis. To 
standardize differences in the formation efficiencies of 3C libraries these interactions are transformed 
by adding or removing CT value to all interactions in that biological replicate, normalizing the interaction 
profile under the assumption the only difference between LIF A1xA2 interaction frequency is due to 
library formation efficiency. Once the data has been transformed it can be graphed in a straight line 
scatter plot. 
For Example: 
 
 
3C Sample non-normalized CT  
(LIF A1xA2) 
normalized CT  
(value = 25) 
Proliferative 26.72 25.00 (-1.72 CT to all other CT) 
Quiescence 24.84 25.00 (+0.16 CT to all other CT) 
Rapamycin Treated 26.34 25.00 (-1.34 CT to all other CT) 
 
Interaction Frequency Calculation 
  To measure interaction frequency the normalized Ct value undergoes the following 
transformation, where 40 is the maximum Ct value possible by qPCR as it represents 40 cycles of 
amplification: 
 
Interaction Frequency = 2^(40-3C Sample CT)  
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Ex. Interaction Frequency  =  2^(40-25) = 32768 
 
Calculation of Error 
  Error is calculated from the standard error of the mean (SEM) between the number of biological 
replicates for each treatment.   
 
(Standard Deviation between biologicals) / Sqrt (# of biological replicates) 
 
  To use this error in the profile the result must undergo a transformation/interpretation of the 
appropriate range of error. 
 
  Maximum Error = Interaction Frequency + Error 
 Minimum Error = Interaction Frequency – Error 
  Interaction Frequency Error = (Maximum Error - Minimum Error)/2 
 Graphing 3C Data 
  Once the data has been transformed it can be plotted in a straight-line scatter. The data is 
plotted with the Y-axis set as the interaction strength of the assayed interaction, and the X-axis as the 
distance of assayed interaction from the anchor. 
 
2.10 3C Product Size Confirmation 
 
  Correct product formation in 3C-qPCR analysis was confirmed by electrophoresis to separate 3C 
qPCR products and sizing the resulting bands on either a 6% TBE or a 6% SB gel. As our 3C technique and 
analysis was developed, we transitioned from analyzing the size of PCR fragments on a 2% agarose gel, 
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to either a 6% TBE gel (Figure 2-4) or 6% SB gel (Figure 2-5). These gels provided much higher resolution 
than the 2% agarose gel and made confirming correct product size easier. The observed size of 3C qPCR 
products was compared to the theoretical size of the fragment, calculated by combining the linear 
distances from the beginning of each primer sequence to the restriction site (the ‘amplicon 
contribution’) and adding six base pairs to accommodate for the site of the restriction site. By combining 
the qPCR melt-curve data to this analysis, we were able to confirm that the correct and unique product 
was being formed.  
 
Figure 2-4: Sizing of PCR Products by Tris-Borate Gel. Separation of several 3C early qPCR products on a 
6% TBE gel. A 1 kB DNA ladder (Invitrogen, USA, Cat #: 10488090) was used to estimate product sizes. 
TBE Gels provide much higher band resolution compared to agarose gels, even between products of 
similar sizes. Many 3C primers were designed to amplify final products ranging 100-300 bp and TBE gels 
effectively resolved this size range.   
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Figure 2-5: Sizing of PCR Products by Sodium Borate Gel. Separation of several later 3C qPCR products 
on a 6% sodium borate (SB) gel. A 1 kB DNA ladder (Invitrogen, USA, Cat #: 10488090) was used to 
estimate product sizes. 6% SB gels provided even better band resolution than 6% TBE gels and were also 
able to separate of low (100-250 bp) size products. These gels could also be electrophoretically 
separated in less than 10 minutes.  
 
 
 
2.11 3C Optimization 
  Our 3C protocol has been optimized at several steps of the protocol.  
Cell Harvesting 
  Traditionally the 3C protocol has been performed by initially re-suspending cultured cells with 
Trypsin or Tryple ExpressTM prior to fixation with formaldehyde. In the course of this project we were 
made aware that genome organization at the chromosome level is capable of altering within fifteen 
minutes in response to stimuli (Mehta et al., 2010). As resuspending cultured cells can require as much 
as fifteen minutes to perform, especially if many samples are being prepared at once, a concern was 
raised regarding the re-organization of the genome in response to this resuspension. To try to best 
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preserve the three-dimensional organization of the genome we sought an alternative method of fixing 
cultured cells with formaldehyde. Similar to ChIP and even a recent 3C-ChIP protocol (Tiwari and Baylin, 
2009), we fixed cells in culture without resuspension, instead replacing culture media with serum-free 
media containing 1% formaldehyde. In our initial attempt we discovered cells would not resuspend after 
the addition of trypsin, as expected, and would require the use of cell culture tissue scrapers to liberate 
cells from the plate. This avenue produced three immediate problems. Cells became quite difficult to 
count following scraping and many would be destroyed by the process causing us to lose information on 
exactly how many cells we began with. The collection of cells was less efficient as many were 
unrecoverable from the surface of the plate even following repeated scraping and washing with PBS. 
The resulting cells we did successfully collect endured over 200 strokes with a glass Dounce 
homogenizer in a cold cell lysis buffer. This result lead to a search for alternate methods to isolate and 
permeabilize cell nuclei (discussed in Nuclei Isolation). We were able to create successful 3C libraries 
from this process; however, they suffered from an immediate large loss of cell number which limited the 
production of 3C products and subsequent breadth of analysis. In the end we decided on fixing the cells 
immediately upon resuspension, skipping a five-minute centrifugation step and adding media containing 
formaldehyde directly to the resuspension volume. Resultantly we reduced the time between culture 
and fixation to 7-9 minutes from ~15 minutes. 
 
Nuclei Isolation and Digestion Efficiency 
 Following concerns of nuclei clumping prior to digestion with HindIII, we examined samples 
under a light microscope and observed variable levels of clumping/coalescence. To some degree the 
clumping could be reduced, albeit not entirely, by repeated vortexing and pipetting. However, as this 
was time-intensive for even one sample and we were often working with upwards of six samples, it was 
desirable to find other means to individualize nuclei. Individualization of nuclei is an important step for 
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digestion as clumping occludes nuclei or limits surface area (Figure 2-6), reducing the total amount of 
genomic DNA available for digestion by HindIII in solution and subsequent ligation. Differential surface 
area also biases digestion, as ease of access into genomic DNA will facilitate a gradient wherein the 
nearest-to-surface DNA will be digested more thoroughly and more internalized/occluded DNA will be 
less digested proportional to increased distance from surface. Undigested DNA caused by either 
clumping and complete occlusion of internalized cells or cells whose surface area is unequal due to 
clumping which may cause DNA to remain undigested may look similar to genomic DNA when separated 
during our analysis by separation of samples by 1.0% agarose gel. 
 
 
Figure 2-6: Clumping of nuclei reduces digestion efficiency. Illustration depicting the access of the 
restriction enzyme HindIII to formaldehyde fixed nuclei during the 3C protocol. Height of the red triangle 
in the second figure represents a biased gradient of digestion anticipated across the nuclear volume (in 
a cell with limited surface area due to clumping). Cells at the center of clumps may not be accessible to 
HindIII (or other) restriction enzymes.  
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  To remediate the clumping of isolated nuclei we attempted two changes to the protocol. One 
change was the removal of sodium dodecyl sulphate (SDS) during resuspension, inspired by the 
observation that clumping significantly worsens when the cells were resuspended in restriction enzyme 
digestion buffer containing SDS. Our suspicion was that SDS was increasing the ‘stickiness’ of the nuclei 
and worsening the clumping (SDS is added to solubilize the membrane). Additionally, we also suspected 
that the addition of BSA to coat the nuclei would reduce clumping. As can be observed in Figure 2-7 
both early attempts to reduce clumping caused the opposite effect. Through experience we eventually 
discovered that reducing the speed of the centrifuge during resuspension (a cleanup step) and diluting 
fewer cells in the same volume resulted in less clumping. By evaluating 3C libraries that had digested 
well (>70% digestion) we observed that fewer cells at time of harvest correlated with better digestion. 
These samples were initially thought to be more successful because the restriction enzyme had less 
material to digest; however, it has since been observed that individualization of even a large number of 
initial nuclei in a sample can result in greater than 70% digestion of a target site.  
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Figure 2-7: Modifications to the 3C protocol to mitigate the clumping of nuclei. During troubleshooting 
of the 3C protocol, several methods to reduce clumping were performed. These alterations occur just 
prior to the digestion step with HindIII and involved either no alteration to the protocol (Left), the 
removal of SDS (Middle), and the addition of BSA to coat nuclei and reduce cohesion (Right).  
 
Improved Ligation Efficiencies 
  The ligation step is fundamental to the success of creating 3C libraries, but its reproducibility is 
limited by the level of digestion that occurred to create the necessary sticky/overhang fragments. If 
digestion was complete, it would generate ~900,000 restriction fragments per genome, assuming a 6-
cutter (AAGCTT) restriction enzyme such as HindIII was used. As T4 DNA Ligase is dependent on ATP for 
activity, using one ATP per ligation event, between ~450,000 (one ligation event per pair) to ~900,000 
(all fragments ligated into one strand) molecules of ATP will be consumed. Per million genomes this 
number rises to 4.5 x 10^11 to 9.0 x 10^11 molecules of ATP, or 7.5 E-13 to 1.5 E-12 Mol of ATP. In 
considering these requirements against the ATP provided by the T4 DNA Ligase Buffer (1x) – See Table 
2-2 – it is clear that there is an extreme excess of ATP available in solution even at substantially smaller 
solution volumes. However, several protocols (Hagege et al., 2007; Naumova et al., 2012), either add 
excess ATP to these reactions or delay adding the buffer until just prior to the ligation event. At early 
stages of the developing our protocol we observed some well-digested 3C libraries did not ligate all 
restriction products (Figure 2-8). 
T4 DNA Ligase (1x) 
Buffer Total ATP (mols) 
Required ATP for 10 
Million Cells (Mol) Excess ATP 
Percent ATP 
Consumed 
7 ml Solution 7.00E-06 1.49502E-11 7.00E-06 0.000% 
1 ml Solution 1.00E-06 1.50E-11 1.00E-06 0.001% 
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0.5 ml Solution 5.00E-07 1.50E-11 5.00E-07 0.003% 
Table 2-2: Theoretical Consumption of ATP during the ligation step of 3C. This table describes 3 total 
volumes ligation may be performed in, 7 ml, 1 ml, and 0.5 ml. For each total volume the total mols of 
ATP has been calculated as well as the required ATP by T4 DNA Ligase to complete ligation of a 3C 
library, assuming 100% digestion efficiency. The two rightmost columns describe the excess ATP 
available in solution and the percent total ATP consumed of the solution to complete ligation. 
 
Figure 2-8: Incomplete ligation of 3C libraries. Separation of several 3C library samples on a 1.0% 
agarose gel alongside a 1 kB DNA ladder (Invitrogen, USA, Cat #: 10488090). Some early well-digested (> 
80%) 3C Libraries did not ligate all restriction fragments and present a smear below the ‘3C band’ 
occurring at roughly 10 Kbp.  
 
  Different approaches by other labs (Hagege et al., 2007; Naumova et al., 2012) suggest adding 
the T4 DNA Ligase buffer immediately prior to ligation, avoiding its addition prior to a one-hour 37oC 
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incubation in Triton-X that may have degraded ATP. Though simple, this alteration has resulted in 
libraries produced after the change to having no smear of un-ligated products below the “3C Band” (See 
Agarose Gel Controls). While the exact rationale for the success of this alteration is not clear, several 
labs likely experienced incomplete ligations, despite the theoretical extreme excess of ATP. Storage 
conditions provided by Sigma-Aldrich (Cat #: 51963-61-2) suggest that aqueous ATP rapidly breaks down 
over the course of one-week when refrigerated, or several months when frozen. Additionally, as the 
ligation step of 3C occurs prior to phenol/chloroform extraction, proteinaceous components and debris 
are still present in solution and may consume or sequester ATP. Considering that ATP is a major energy 
currency in biology, is highly unstable, and is shipped as a desiccated powder rather than an aqueous 
solution, the conclusion is possible that early 3C ligation reactions suffered from rapid ATP degradation 
during the hour long incubation at 37°C prior to ligation, possibly amplified by cell debris. 
 
Improved DNA Quantification Accuracy 
  At early stages of this project our 3C libraries suffered from very large (2.1 mg/µl) and 
inaccurate DNA reads following ethanol precipitation (Figure 2-9). Our DNA quantification was 
performed by spectrophotometry (NanodropTM) (example of an early examination is in Figure 2-9). Of 
note is the distinct ‘bumpy’ curve produced during spectrophotometry. This problem, caused by a 
contamination of dithiolthreitol (DTT) which is present in the T4 DNA Ligase Buffer, was originally 
reduced by column purification. However, column purification introduced another step that resulted in 
the loss of total DNA collected at the end of the experiment. As 3C libraries can be quickly consumed by 
analysis, with each replicate of a triplicate for qPCR requiring 100 ng of template, investigation are quite 
limited by the amount of DNA available per biological replicate. During a review of the literature 
(Hagege et al., 2007) we discovered that a simple dilution of the ligation mix (increasing total volume by 
~40%) with water prior to phenol/chloroform extraction and ethanol precipitation prevented DTT from 
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contaminating the precipitated 3C sample. Further improvements to the protocol reduced the total DTT 
in solution by reducing the total ligation volume.  In practice, these alterations have severely reduced 
(possibly eliminated) DTT contamination and entirely removed the need of column purification.  
Accuracy of quantification by spectrophotometry has been verified by loading equal (by 
spectrophotometric read) amounts of a template on an agarose gel (Figure 2-10), as well as by qPCR 
against primers against a genomic DNA site at the EFEMP2 (EGF-containing fibulin-like extracellular 
matrix protein 2) gene. Primers designed against the EFEMP2 gene do not contain a restriction site for 
HindIII and ‘count’ the number of genomes present in a DNA sample. By amplifying EFEMP2 from a 
known concentration of genomic DNA using qPCR, a comparison can be made between this known 
concentration and the unknown concentration of another sample also amplifying EFEMP2. 
 
Isopropanol Precipitation supplants Ethanol Precipitation 
      Early 3C libraries also suffered from contamination from the buffers used during restriction digestion 
and ligation, from cell debris, and from the salt used during the precipitation of DNA.  High salt 
concentration and other persistent contaminants negatively alter the accuracy of quantification by 
Nanodrop spectrometer and required us to measure template concentration by using EFEMP2 
(mentioned earlier). Initially the DNA precipitation step was performed in a large volume (>35 mL, 
containing final concentration of 70% ethanol and 150 mM sodium acetate). This precipitation 
commonly required several days to complete (stored at RT or -20°C) and originally contained large 
amounts of DTT and precipitated salt (noted by the appearance of a strong white pellet). Additionally, 
the accompanying digestion efficiency sample (collected as 10% of the total volume of sample following 
digestion) often yielded weak or absent pellets compared to expectations based on 3C library pellets. In 
suspecting that the large volume, contaminants, and low DNA content of DE samples were problematic 
we supplanted the ethanol precipitation. We introduced an isopropanol precipitation (4°C, 20 minutes, 
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1:1 isopropanol, 10% (v/v) 3M NaOAc) aided by 1 ul of 20 mg/ml glycogen). This change increased the 
yield and speed of precipitation for 3C samples; the yield, speed of precipitation, and reliability of visible 
pellet formation for DE samples.  
 
 
Figure 2-9: Computational output of 3C samples by Thermo Scientific Nanodrop 2000. 3C libraries were 
quantified using a Thermo Scientific Nandrop 2000. Early 3C samples suffered from contamination with 
dithiolthreitol (DTT) that caused an erroneous and inflated estimation of DNA. Spectra of a DTT-
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contaminated 3C sample (A) and a DTT-free 3C sample (B) are shown above, as measured by a Thermo 
Scientific Nanodrop 2000.  
 
 
Figure 2-10: Modification to DNA precipitation increases the accuracy of DNA quantification. 
Separation of 3C libraries on a 1.0% agarose gel alongside a 1 kB DNA ladder (Invitrogen, USA, Cat #: 
10488090). In each lane, 300 ng of sample was loaded as measured by a Thermo Scientific Nanodrop 
2000. (A) Early 3C samples suffered from inaccuracy in quantification. (B) Later 3C samples benefitted 
from increased accuracy in quantification due to higher purification and reduction of DTT 
contamination.  
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3.0 Results: Analysis of chromosome territory positioning in response to 
quiescence induction or Rapamycin treatment. 
  Genome organization in the 3D nuclear volume can alter in response to stimuli. In earlier assays 
performed in the Eskiw laboratory (Gillespie et al., 2015) and others (Mehta et al., 2010) a 
reorganization of chromosome territory position has been noted for both chromosomes 10 and 18 
following induction of quiescence and treatment with 500 nM Rapamycin using FISH. These alterations 
occurred alongside changes to gene expression as measured by RNA-Seq (Table 3-1). For the purpose of 
this thesis, these experiments have been recapitulated and expanded upon by the addition of 
chromosome 4, which contains a cluster of chemokine genes up-regulated by treatment with 500 nM 
Rapamycin. Considering the up-regulation of this cluster of genes we anticipated that chromosome 4 
will reposition in the nuclear volume in response to treatment with Rapamycin in our 2DD human 
foreskin fibroblast cell line. 
  Identical to work previously performed, cells were cultured in proliferative, quiescent (0.5% 
FBS), or Rapamycin-treated (500 nM) conditions and subjected to analysis by FISH and subsequent 
erosion analysis. Specifically, in FISH chromosomes are ‘painted' using probes that hybridize to strands 
of a target chromosome in the presence of a Hoechst 33342 (H33342) stain that stains all chromatin 
non-specifically. By quantifying the signal produced from each chromosome and standardizing these 
values against the non-specific DNA signal produced by H33342 staining, the exact positioning of each 
chromosome can be characterized. In this characterization known as Erosion Analysis (Figure 3-1) each 
nucleus is divided into five concentric rings of equal area and the chromosome occupancy per ‘shell’ or 
ring is given a numerical value. By comparing these profiles in each treatment, the repositioning of 
chromosome territories can be measured. Chromosome X was used as a control. 
   Repositioning of a chromosome is suggestive of altered gene expression. It has been previously 
observed that positioning towards the nuclear interior relates to increased expression of contained 
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genes and positioning near the exterior related to decreased expression of contained genes. 
Chromosome positioning; however, has other features to consider such as which chromosomes are 
neighbours. By repositioning two chromosomes closer together in the nuclear volume, trans- 
interactions that were previously impossible can now occur such as between an enhancer and a 
promoter. Furthermore, relocating a chromosome may allow access to a specialized transcription 
factory previously denied by positioning, or may facilitate the rapid expulsion of newly transcribed 
mRNA from the nucleus by occupying a more peripheral position. Chromosome 4 contains a cluster of 
chemokine genes up-regulated in response to Rapamycin. How this chromosome alters position in 
response to this up-regulation may inform on the underlying processes organizing chromosome 
territories. Alternately, repositioning of this chromosome may be responsible for the up-regulation, by 
allowing contained genes to interact with nuclear elements previously denied, such as transcription 
factories or other chromosomes. Chromosome 4 contains a cluster of CXCL genes that are up-regulated 
in response to Rapamycin. This ‘chemokine cluster’ serves as a good target to investigate, to 
characterize if repositioning of the chromosome is necessary for increased expression. In the following 
experiments we measured the positioning of chromosome 4, 10, 18, and X. 
 
 
Figure 3-1: Schematic of fluorescence in situ hybridization image collation and erosion analysis. Images 
were captured using Fluorescence microscopy for chromosomes of interest (4, 10, 18, X) and are 
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computationally merged prior to Erosion analysis. H33342 dye is used to stain the genome non-
specifically. Chromosome-specific probes containing fluorophores are used to identify targeted 
chromosomes. During Erosion analysis the positioning of chromosomes is quantified in each of five 
concentric rings of equal area.  
 
 
Table 3-1: Gene from chromosome 4 (74-75 Mbp) are differentially regulated in response to 
quiescence and Rapamycin.  Summarized changes in regulation of multiple genes on chromosome 4 
from an RNA-Seq data (Gillespie et al, 2015) (GEO Accession: GSE65145). Each treatment condition 
(proliferative, quiescent, Rapamycin) had two biological replicates. Fold change is measured in 
comparison to proliferative samples. Samples were either induced into quiescence by reducing media 
serum to 0.5% or by treating cells with 500 nM Rapamycin for 5 days. Contained genes occur in a cluster 
of Chemokine C-X-C Motif Ligand genes on chromosome 4 region 74 Mbp (CXCL8, CXCL6, CXCL1, CXCL3, 
and CXCL2) that were discovered up-regulated at this location during treatment with 500 nM Rapamycin 
in the 2DD normal human dermal fibroblast cell line. 
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3.1 Chromosomes 10 and 18 reposition in response to quiescence induction and 
Rapamycin treatment  
 In agreement with earlier results (Gillespie et al., 2015; Mehta et al., 2010), I observed a 
repositioning of chromosomes 10 and 18 in both quiescence and Rapamycin-treated conditions. In 
proliferative cells, chromosome 10 occupies a central position in the nucleus (shells 4 and 5, the most 
internal shells) (Table 3-2). In Rapamycin-treated cells a repositioning of chromosome 10 to shells 1 and 
2 (the most external shells) was observed. Similarly, this repositioning of chromosome 10 from shells 4 
and 5, to shells 1 and 2 was also observed in quiescent cells. Chromosome 18, which occupies a 
peripheral position (shells 1 and 2) in proliferative cells, also underwent a significant nuclear 
repositioning. For both quiescence and Rapamycin-treated, chromosome 18 repositioned to the 
innermost shells (4 and 5). In all three treatments chromosome X displayed little or no movement and 
serves as a control for these experiments.  
  These results validate earlier findings and confirm our three growth conditions are altering 
genome organization in a predictable and repeatable manner. While the significance and exact effect 
upon gene expression from this repositioning is not clear, the genome is re-organizing in response to 
both of our treatments compared to proliferative cells. Furthermore, these results display the capability 
of the genome to significantly alter the position of chromosomes in response to stimuli. As this 
repositioning is reproducible and has been previously observed, it suggests it provides a function to the 
cell. However, our current investigations are focused on the organization and repositioning of 
chromosome 4. 
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Figure 3-2: Positioning of several chromosome territories during proliferative, quiescent, or 
Rapamycin-treated conditions. Bar graphs depicting the results of erosion analysis on images collected 
by fluorescence microscopy. During erosion analysis the nucleus is divided into five concentric rings of 
equal area, with shell 1 being the most external and shell 5 being the most internal. Height of bars is 
determined by the ratio of specific chromosome painting divided by strength of Hoechst 33342 staining 
for the relevant shell. Below each graph are representative images of cells from each treatment. 
Chromosomes of interest are stained red and DNA is non-specifically stained blue with DAPI. (* = P < 
0.05.) Pro = proliferative, Qui = quiescence cells, Rap = Rapamycin-treated cells. Representative images 
for each treated and chromosome were collected from at least 30 nuclei images. 
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Table 3-2: Summarized results of chromosome territory positioning during proliferative, quiescent, 
and Rapamycin-treated conditions. Left) Summarized results following quantification of chromosome 
positioning by Erosion Analysis. Numerical data of chromosome shell occupancy has been simplified to a 
positioning (Central or peripheral) and the two shells with the highest chromosome signal relative to 
H33342 ratios. Right) Image depicting the numbering system for Erosion Analysis. Shell 1 represents the 
most peripheral shell while shell 5 is the most central. (Erosion Analysis image credit: Zoe Gillespie). 
 
3.2 Chromosome 4 repositions in response to quiescence induction 
  Chromosome 4, which contains our cluster of chemokine genes of interest at 74 Mbp, has yet to 
be characterized by FISH in all three treatment conditions. We observed an up-regulation of these 
chemokine genes on chromosome 4 in our RNA-Seq data set, from this we anticipated a repositioning of 
chromosome 4 in the nuclear volume in response to increased expression of these genes. 
  We performed analysis by DNA-FISH on chromosome 4 (Figure 3-2, Table 3-2), and 
characterized chromosome 4 position in shells 2 and 3 in proliferative cells. When treated with 
Rapamycin or induced into quiescence, there was a shift in positioning to a more peripheral position. In 
both quiescence and Rapamycin-treatment the highest occupancy shifted from shells 2 and 3 to shells 1 
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and 2. During Rapamycin treatment this test is non-significant (P > 0.05); however, in quiescent cells the 
movement towards the periphery is more pronounced and is significant (P < 0.05). 
 
3.3 Discussion 
 Overall these findings on the repositioning of chromosome 18 and 10 during Rapamycin 
treatment and quiescence induction indicate treatments were successful in reproducing earlier results 
(Gillespie et al., 2015; Mehta et al., 2010), confirming that the genome is capable of re-organizing in a 
predictable and repeatable manner, and that our treatments are behaving as seen previously. These 
examinations by DNA-FISH were expanded upon to include chromosome 4, which contains our cluster of 
chemokine genes of interest at region 74 Mbp. In proliferative cells chromosome 4 occupies a position 
near the periphery. However, during treatment this positioning only slightly alters in quiescent and 
Rapamycin-treatment to an even more peripheral position. Though subtle, this chromosome territory 
repositioning was significant (P<0.05) during quiescence induction; however, the effect non-significant 
in Rapamycin-treated cells.  
  Interestingly, there was not a significant repositioning during the up-regulation of genes by 
Rapamycin-treatment. Furthermore, we did observe a repositioning of chromosome 4 to the periphery 
during quiescence, which displays lower expression of the chemokine genes of interest (CXCL8, CXCL6, 
CXCL1, CXCL3, CXCL2). Despite the up-regulation of these CXCL genes during Rapamycin treatment we 
did not observe significant repositioning of the chromosome. This may indicate that the up-regulation of 
a single cluster of genes is not enough to re-position the whole chromosome, and rather a more subtle 
effect may be occurring at sub-chromosomal levels. 
  Previous analyses indicate a correlation repositioning of chromosomes towards the nuclear 
periphery with decreased transcription of contained genes, though this relationship is incomplete and 
warrants further investigation. In the context of observed changes for quiescent cells, which have 
71 
 
reduced gene expression of the chemokine cluster, chromosome 4 did move to a more peripheral 
position. However, we did not observe a repositioning to the interior during treatment with Rapamycin 
that upregulated expression of several genes on chromosome 4. It is possible that many factors are at 
play, such as the expression of other genes on the chromosome, which may also influence the 
chromosome to a more internal or peripheral position. 
  The nucleus is a highly dynamic and crowded organelle. Many factors orchestrate this 
organization and perhaps the changes to three-dimensional organization of chromosome 4 are occurring 
more subtly – at the ‘sub-chromosomal’ level. At this sub-chromosomal level, alterations in three-
dimensional organization manifest as enhancer-promoter interactions, or as interactions occurring 
between genes caught in the proximity of the same transcription factory. These subtle changes would 
not be measurable by DNA-FISH, due to optical microscopy limitations. Investigation at this level 
requires the use of the 3C technique, wherein local folding and interactions of a DNA strand can be 
characterized.  
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4.0 Results: 3C Analysis of CXCL Locus on Chromosome 4 
  Previously, analysis of RNA-Seq data of Rapamycin-treated primary human foreskin fibroblasts 
(2DD) identified a region on chromosome 4 (region 74 Mbp) which contained many chemokine genes 
that were Up-regulated. These genes are members of the chemokine C-X-C motif ligand (CXCL) family 
and include CXCL8, CXCL6, CXCL1, CXCL3, CXCL2. These genes are contained in a putative TAD spanning 
~360,000 base pairs on chromosome 4.  Many of these genes have roles in regulating growth and 
proliferation and have been ascribed roles in many cancers (commonly referred to as Growth Related 
Oncogene (GRO) , , or  in cancer) (Dehghani et al., 2005; Kim et al., 2015). These CXCL genes were 
discovered in tight sequence proximity on chromosome 4 that changed expression in response to 
treatment with 500 nM Rapamycin treatment, based on RNA-seq data (See Table 3-1) (Gillespie et al., 
2015). As the expression of these CXCL genes all increased following Rapamycin-treatment, we 
suspected these genes would coalesce in three-dimensional space during transcription at a transcription 
factory, recruited by the transcription factor Signal Transducer and Activator of Transcription 5A/B 
(STAT5A/B).  Earlier work from the Eskiw lab indicated that STAT5A/B mediates changes in transcription 
profile of cells treated with Rapamycin (Gillespie et al., 2015).   
  The observation that a cluster of chemokine genes was up-regulated by Rapamycin treatment, 
provided a candidate region of the genome to test if the up-regulation of genes equated to re-
organization of sub-chromosomal domains. Furthermore, with the idea of the transcription factory in 
mind, we hypothesized that this cluster of genes likely shared a single transcription factory, or a cluster 
of factories containing similar transcriptional machinery, and may come together (more frequently) in 
three-dimensional space during up-regulation. Lastly, this cluster of chemokine genes on chromosome 4 
also provided an example of a possible TAD, which is a cluster of like-regulated genes with boundaries 
that isolate its interaction with external elements while facilitating internal interactions. To test these 
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hypotheses, we performed 3C on a primary normal human foreskin fibroblast cell line (2DD) in three 
conditions: proliferative (10% FBS), quiescent (0.5% FBS), and Rapamycin-treated (500 nM). 
  In the 3C assay, cultured cells are incubated with formaldehyde and the resulting fixed nuclei 
are isolated for downstream steps. These nuclei are then incubated with a restriction enzyme (HindIII) 
that digests the genome at known sequences (AAGCTT). Following digestion formaldehyde linked 
restriction fragments are then ligated with T4 DNA ligase to produce a ‘3C Library’. These libraries 
contain ligated fragments that represent three-dimensional interactions occurring in the genome and 
are detectable by qPCR. By designing primers to flank restriction sites in our region of interest (for 
example, chromosome 4, region 74 Mbp), combinations of these primers can be used to characterize 
the local folding environment. This interaction is measured as ‘interaction frequency’. To measure this 
qPCR is performed to measure the presence or absence of 3C products. These values are then 
normalized to an interaction that does not change during treatment. For these assays, 3C data was 
normalized to a pair of neighboring restriction fragments at the LIF gene. When no interactions are 
occurring, interaction frequency decreases as distance between two restriction fragment increases. 
Neighboring restriction fragments provide an accurate way of normalizing data due to their high 
occurrence rate due to minimal linear distance and can only be detected when a 3C product has been 
successfully produced. This is accomplished by using two 3’ or reverse primers that cannot amplify 
genomic DNA that has not been digested, ligated, and inverted.  Normalized interaction frequencies are 
measured in fold change as compared to the minimal level of detectable product (‘background noise’). 
  To characterize a region of interest, such as the chemokine cluster on chromosome 4, an anchor 
fragment must be selected. This anchor fragment is a constant fragment that is used in combinations of 
other nearby sites. For example, analysis of the chemokine cluster used CXCL8 as an anchor which was 
used in combination with all sites of interest in the region (other CXCL genes). By measuring these 
interaction frequencies, a 3C profile can be generated based on the interactions occurring between the 
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anchor (CXCL8) and sites of interest, and summarily plotted. For the chemokine cluster on chromosome 
4, region 74 Mbp, this was performed using both CXCL8 and CXCL1 as anchor fragments. 
   
4.1 CXCL8 anchored interactions in the chemokine locus on chromosome 4. 
  Previously, we identified up-regulation of five chemokine genes in response to treatment with 
500 nM Rapamycin. We further discovered that five of these genes (CXCL8, CXCL6, CXCL1, CXCL3, CXCL2) 
are clustered on chromosome 4, region 74 Mbp in a putative TAD. During treatment with Rapamycin 
these genes were all up-regulated (CXCL8: 28.5-fold, CXCL6: 2.6-fold, CXCL1: 6.4-fold, CXCL3: 6.3-fold, 
CXCL2: 3.2-fold) and during quiescence they were all discovered to be down-regulated (CXCL8: 0.41-fold, 
CXCL6: 0.66-fold, CXCL1: 0.43-fold, CXCL3: 0.19-fold, CXCL2: 0.40-fold). From this analysis, it was 
identified that these genes were co-regulated by common transcription factors (including STAT5A/B).  
  Our hypothesis for this cluster of CXCL genes had two elements; we suspected these genes are 
like-regulated and may be coming together in three-dimensional space for transcription, and that this 
would occur at a shared transcription factory. We suspected that Rapamycin-treatment was driving the 
entire cluster to engage more actively with a transcription factory, and during quiescence the cluster 
shifted away from a transcription factory to decrease transcription. During transcription at a 
transcription factory, interactions occurring between co-transcribed genes would be detectable. 
Conversely, genes being transcribed less (such as during quiescence) would display decreased or non-
detectable levels of interaction frequencies. By analyzing the interaction frequencies between the 
genes, we would be able to characterize if the genes are interacting more during transcription, and if 
they are coming together at a single shared site for transcription.  
 
  My initial analysis used CXCL8 as an anchor, as it was the most highly up-regulated gene in the 
cluster. We measured CXCL8 interaction frequencies with several nearby downstream sites, including a 
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set of control sites and the nearby CXCL genes. These sites include ‘Range-finding sites’ (RFS) to measure 
the decay of interaction frequency as linear distance increases (RFS1: ~5000 bp, RFS2: ~15,000 bp, RFS3: 
~25,000 bp), and the nearby CXCL genes (CXCL6: 96,600 bp, CXCL1: 128,800 bp, CXCL3: 297,700 bp, 
CXCL2: 360,000 bp).  
  To verify the success of our 3C libraries, we first tested the anticipated decrease of interaction 
frequency as linear distance increased from the CXCL8 restriction fragment (Figure 4-1, Table 4-1) to 
nearby control sites. We tested this anticipated decrease interaction frequency using 3 sites, RFS1, RFS2, 
RFS3. As expected, we observed a strong interaction frequency between CXCL8 and RFS1 (~5000 bp 
distance) in all three treatment conditions as measured in arbitrary interaction strength units above 
background (Pro: 741 AU, Qui: 828 AU, Rap: 755 AU). The next site (RFS2, ~15,000 bp) displayed 
significantly decreased interaction frequencies in all conditions (Pro: 98.0 AU, Qui: 188 AU, Rap: 212 AU) 
representing a 7.6- fold reduction in proliferative, 4.4-fold reduction in quiescence and 3.6-fold 
reduction in Rapamycin treated samples. For RFS3 (~25,000 bp distance), we observed proliferative cells 
had an AU value of 65.6, quiescent cells had 270 AU and Rapamycin treated samples had an interaction 
strength of 390 AU. We anticipated that since these were non-coding regions that there would be a 
decrease in all interactions with CXCL8 as distance from the CXCL8 anchor increased. This was the case 
for proliferative cells at 25 Kb distance (exhibiting a 0.09-fold interaction frequency compared to the 5 
Kb distance); however, there was an unexpected increase in interaction strength between these sites in 
both quiescent cells (4.1-fold) and Rapamycin-treated cells (6.0-fold) samples as compared to the 15 Kb 
distance.   Interestingly, this increase in interaction frequency between CXCL8 and RFS3 in quiescent and 
Rapamycin-treated cells may be a functional interaction with a currently unknown element (e.g. 
Enhancer).  
  Next we measured the interaction frequency between CXCL8 and the downstream CXCL genes 
(in linear order: CXCL6, CXCL1, CXCL3, and CXCL2). Interaction frequency between CXCL8 and CXCL6 
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(96,600 bp) was similar in quiescence (0.91- fold, relative to proliferative) and decreased Rapamycin-
treatment (0.48-fold, compared to proliferative) (Pro: 316 AU, Qui: 289 AU, Rap: 150 AU, compared to 
background). Interestingly, these interactions occurred with higher frequencies than interactions 
occurring between CXCL8 and the nearby (~15,000 bp) RFS2 site, despite being positioned nearly 
100,000 bp apart indicating that this may be a functional interaction based on folding and not proximity 
of these regions on the linear genome. The interaction frequency between CXCL8 and CXCL1 (128,800 
bp distance) was similar for proliferative and Rapamycin treated samples (0.89-fold, relative to 
proliferative); however, it dropped significantly (P < 0.10, Student’s 2-tailed T-test) in quiescent cells 
(0.25-fold, relative to proliferative) (Pro: 347 AU, Qui: 88.4 AU, Rap: 310 AU, compared to background). 
For the interaction frequency between CXCL8 and CXCL3 (297,700 bp), we discovered similar and 
comparatively weak interaction frequencies for all three treatments (Pro: 32.6-fold, Qui: 33.7-fold, Rap: 
26.5-fold, compared to background) and was unchanged between the treatments (Qui 1.0-fold change 
and Rap 0.8-fold change compared to proliferative). Lastly, we identified a significant (P < 0.05, 
Student’s two-tailed t-test) increase in interaction frequency between CXCL8 and CXCL2 (360,000 bp 
distance) in quiescence cells (27.3-fold, relative to proliferative) compared to proliferative and 
Rapamycin-treated (Pro: 12.3-fold, Qui: 335-fold, Rap: 22.3-fold, compared to background).  
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Figure 4-1: 3C profile of the CXCL locus on chromosome 4, region 74 Mbp with CXCL8 as the anchor 
fragment. (A) Graphed 3C profile of interactions occurring between the CXCL8 gene and seven 
downstream sites (marked above graph). Interaction frequency is measured by fold change in 
comparison to detected products that have been normalized to a control interaction (between 
neighboring restriction fragments at the LIF gene) against background. Genomic distance is measured as 
the distance between the tested site and the anchor (at the vertical axis). (B) Relative expression of 
several CXCL genes during three different treatment conditions as determined by RNA-Sequencing 
(Gillespie et al, 2015) (GEO Accession: GSE65145). Height of bars indicates fold change in gene 
expression compared to proliferative values. Pro = proliferative (10% FBS), Qui = quiescence (0.5% FBS), 
Rap = Rapamycin Treated (500 nM). (* = P < 0.10, ** = P < 0.05, Student’s two-tailed t-test). (n = 5 
biological replicates for each treatment). 
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Table 4-1: CXCL8 anchored 3C investigations of chromosome 4 (74-75 Mbp) relative to proliferative 
samples. Table depicting interaction frequency relative to proliferative samples for examined 3C 
interactions on chromosome 4, region 74 Mbp between five chemokine C-X-C motif ligand (CXCL) genes 
and ‘Range-finding sites’ (RFS) located near CXCL8. Interactions are defined by a pair of primers with one 
primer chosen as a constant or ‘anchor’ primer for the assays and another as a variable primer. Distance 
is measured from the site of the anchor primer to the site of the variable primer. Fold change is 
calculated as a ratio of interaction frequency compared to proliferative samples using the same primer 
pair. (** = P < 0.05, * = P < 0.10. Student’s 2-tailed T-test.) 
 
4.2 CXCL1 anchored interactions in the chemokines locus on chromosome 4, 
region 74 Mbp. 
  To further characterize the organization of the chemokine cluster on chromosome 4, we chose 
CXCL1 as a second anchor to probe the region (Figure 4-2). CXCL1 was chosen due to it having the 
second highest up-regulation during treatment with Rapamycin (6.4 fold) and that it resides in a more 
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central position in the chemokine cluster than CXCL8. Additionally, by incorporating a second anchor site 
in our analysis to identify potential biases caused by using only a single anchor site. As discussed 
previously, interaction frequency between CXCL1 and CXCL8 (128,800 bp distance) decreases 
significantly in quiescent cells (0.25-fold, relative to proliferative, P < 0.10) compared to proliferative and 
Rapamycin-treated cells (Pro: 347 AU, Qui: 88.4 AU, Rap: 310 AU compared to background). For 
interaction frequency occurring between CXCL1 and CXCL6 (32,200 distance, the nearest CXCL gene), we 
observed a decrease in interaction frequency in quiescent cells (0.83-fold, relative to proliferative) and 
an increase in interaction frequency with Rapamycin-treated cells (1.22-fold, relative to proliferative) 
(Pro: 673 AU, Qui: 558 AU, Rap: 819 AU, compared to background). The interactions between CXCL1 and 
CXCL6 (32,200 bp) occur at similar frequencies to CXCL8 and RFS1 at only ~5,000 bp distance. Interaction 
frequencies between CXCL1 and CXCL3 (168,000 bp distance) increased during quiescence (1.34-fold, 
relative to proliferative) and Rapamycin treatment (1.39-fold, relative to proliferative) compared to 
proliferative cells (Pro: 109 AU, Qui: 146 AU, Rap: 152 AU compared to background). Lastly, CXCL1 and 
CXCL2 interaction frequency increases during Rapamycin-treatment (2.21-fold, relative to proliferative) 
and is similar to proliferative cells during quiescence (1.09-fold, relative to proliferative) (Pro: 120 AU, 
Qui: 131 AU, Rap: 267 AU, compared to background).  
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Figure 4-2: 3C profile of the CXCL locus on chromosome 4, region 74 Mbp with CXCL1 as the anchor 
fragment. (A) Graphed 3C profile of interactions occurring between the CXCL1 gene and other CXCL 
genes nearby (CXCL8, CXCL6, CXCL3, CXCL2). Interaction Frequency is measured by fold comparison of 
detected products that have been normalized to a control interaction against background. Genomic 
distance is measured as the distance between the tested site and the anchor position (at ‘0’ or the 
vertical axis). (B) Relative expression of several CXCL genes during three different treatment conditions 
as determined by RNA-Sequencing (Gillespie et al, 2015) (GEO Accession: GSE65145). Height of bars 
indicates fold change in gene expression compared to proliferative values. Pro = proliferative (10% FBS), 
Qui = quiescence (0.5% FBS), Rap = Rapamycin Treated (500 nM). (* = P < 0.10, ** = P < 0.05, Student’s 
two-tailed t-test). (n = 5 biological replicates for each treatment). 
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Table 4-2: CXCL1 anchored 3C investigations of chromosome 4 (74-75 Mbp) relative to proliferative 
samples. Table depicting interaction frequency relative to proliferative samples for examined 3C 
interactions on chromosome 4, region 74 Mbp between several chemokine C-X-C motif ligand (CXCL) 
genes. Interactions are defined by a pair of primers with one primer chosen as a constant or ‘anchor’ 
primer for the assays and another as a variable primer. Distance is measured from the site of the anchor 
primer to the site of the variable primer. Negative distances indicate the variable primer is upstream of 
the anchor primer. Positive distances indicate the variable primer is downstream of the anchor primer. 
Fold change is calculated as a ratio of interaction frequency compared to proliferative samples using the 
same primer pair. (** = P < 0.05, * = P < 0.10. Student’s 2-tailed T-test.) 
 
  We investigated if interactions could be detected between the CXCL2 gene (occurring in one 
putative TAD) and the nearby epiregulin (EREG) gene occurring in a second, neighboring, putative TAD 
(Table 4-3). If an interaction was detectable between AREG or EREG and the CXCL2 gene, it would 
suggest they may be occupying a single TAD rather than two TADs. We detected interaction frequencies 
occurring between EREG and AREG which supports the idea that EREG and AREG occupy the same TAD 
(Pro: 1.00-fold, Qui: 1.94-fold, Rap: 1.89-fold, relative to proliferative samples) (Pro: 3502-AU, Qui: 6780 
AU, Rap: 6623 AU as compared to background). However, we were unable to detect interactions 
occurring between the CXCL2 gene and AREG or EREG, suggesting EREG and AREG occupy a different 
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TAD than the CXCL genes of interest. 
 
 
Table 4-3: EREG anchored 3C investigations of chromosome 4 (74-75 Mbp) relative to proliferative 
samples. Table depicting interaction frequency relative to proliferative samples for examined 3C 
interactions on chromosome 4, region 74 Mbp between the EREG, AREG, and CXCL2 genes. Interactions 
are defined by a pair of primers with one primer chosen as a constant or ‘anchor’ primer for the assays 
and another as a variable primer. Distance is measured from the site of the anchor primer to the site of 
the variable primer. Negative distances indicate the variable primer is upstream of the anchor primer. 
Positive distances indicate the variable primer is downstream of the anchor primer. Fold change is 
calculated as a ratio of interaction frequency compared to proliferative samples using the same primer 
pair.  
 
 
4.3 Discussion 
  Our analysis of the cluster of chemokine genes on chromosome 4, region 74 Mb, revealed 
several aspects of the local organization of this putative TAD. The initial analysis of interaction decay, 
using sites located at 5,000, 15,000, and 25,000 bp away from the CXCL8, displayed high interaction 
frequency at 5,000 bp (Average: 775-AU), lower interaction frequency at 15,000 bp (Average: 166-AU), 
and even lower interaction frequency at 25,000 bp in proliferative cells (Pro: 66-AU). Interestingly, 
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quiescent and Rapamycin-treated cells displayed increased interaction frequency (Qui: 4.12-fold, Rap: 
5.96-fold relative to proliferative) between CXCL8 and this site 25,000 bp away (Qui: 270 AU, Rap: 390 
AU compared to background), and were forming functional but currently uncharacterized interactions.  
  For the CXCL genes of interest on chromosome 4, a complicated folding pattern of these region 
was identified. CXCL8 interacted more strongly with CXCL2 following quiescence induction; however, 
quiescent treatment decreased the interaction strength with CXCL1. This loss of interaction strength 
may be indicative of a gain of interaction with CXCL8 with other segments of this regions (such as CXCL2) 
or CXCL1 favoring other interacting partners. Rapamycin appeared to have a slight change in interaction 
strength with CXCL2 but did not meet our criteria for significance. These observations suggest that this 
region of the genome might be already folded for the expression of these genes in response to 
rapamycin treatment, and that little re-organization is required for dramatic changes in expression. The 
significance of the relationship between CXCL8 with CXCL1 and CXCL2 in response to quiescence remains 
to be elucidated. However, we did provide evidence that the CXCL genes are clustered in a TAD separate 
from the neighboring EREG and AREG genes.  
 While many interactions occur at high frequency during all growth conditions, our analyses 
revealed several aspects of the genes contained inside this putative TAD on chromosome 4, located 
between 74 and 75 Mbp. On average, we observed a higher interaction frequency for interactions in 
either proliferative or Rapamycin-treated cells, as compared to quiescent cells. Interestingly, 
proliferative and Rapamycin-treated cells displayed a similar organization, perhaps due to both growth 
conditions having above a certain level of transcription. In contrast, the lowered transcription during 
quiescence may be weakening these interaction frequencies. In the case of the increased interaction 
frequency between CXCL8 and CXCL2 in quiescent cells, this may be the result a different interaction 
forming. Each growth condition also displayed unique aspects. Both quiescent and Rapamycin-treated 
cells displayed increased interaction frequency between CXCL8 and the RFS3 site ~25,000 bp upstream 
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of the CXCL8 gene compared to proliferative cells. Quiescent cells uniquely featured a detectable 
interaction between CXCL8 and CXCL2 (360,000 bp apart) that was absent in both proliferative and 
Rapamycin-treated cells and had a significantly weakened interaction between CXCL8 and CXCL1 
(128,800 bp). From these results it seems the organization of this region on chromosome 4 may alter 
during different growth conditions; however, some of the changes are subtle and are not simply the loss 
or gain of interactions.  
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5.0 Results: 3C Analysis of other loci 
  Following our analysis of the region on chromosome 4 containing five chemokine genes, we 
investigated two other regions of the genome encoding genes with differential expression in response 
to Rapamycin treatment or quiescence induction to determine if they also re-organized. The first region 
contained the Leukemia inhibitory factor (LIF) gene on chromosome 22, and the second, a cluster of 
KRTAP genes on chromosome 17, region 41 Mb. These regions were selected based on our previous 
observations that LIF was up-regulated 86-fold during treatment with 500 nM Rapamycin (Gillespie et al 
2015) and upon examination of the region using the UCSC Genome Browser we discovered several 
nearby sites featuring histone 3 lysine 27 acetylation (H3K27Ac) marks that denote possible enhancers 
for the gene, as well we observed possible ‘eRNA’ (enhancer RNA) being produced at a site near the LIF 
gene in our RNA-Seq data (Figure 5-1). eRNA is produced from enhancers caught by transcriptional 
machinery and appear as short RNA fragments that match intergenic sequences (Rothschild and Basu, 
2017).  Considering the up-regulation of LIF during treatment with Rapamycin, this was an ideal 
opportunity to identify the location of this enhancer and confirm if the possible eRNA signal matches the 
location of this enhancer, and to observe the possible interaction between the promoter of LIF and its 
nearby enhancer during up-regulation. To discover the location of the LIF enhancer, LIF was used as the 
anchor and primers were designed against ten nearby sites that captured possible enhancers. These 
sites were selected by the presence of H3K27Ac (enhancer) marks in the UCSC Genome Browser (for 
various cell lines). 
  A region was discovered, containing multiple KRTAP genes that were up-regulated during 
Rapamycin treatment. Using computational tools that identified groups of genes responding to stimuli 
within a specific window distance, this region was identified on chromosome 17. Like our earlier analysis 
of the chemokine genes on chromosome 4, we hypothesized that co-transcription and localization of 
these genes to a transcription factory would be observable during treatment with Rapamycin. To 
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analyze the KRTAP region on chromosome 17, we utilized two genes as anchors, KRTAP2-3 and KRTAP4-
5.  
 
 
Figure 5-1: Screen capture of the Seq-Monk software used to analyze RNA-Seq data produced for 
proliferative, quiescent, and Rapamycin-treated 2DD cells (Gillespie et al, 2015) (GEO Accession: 
GSE65145). The image captures a section of chromosome 22, between 30,630,000 and 30,650,000 bp. 
Sequence read alignments are displayed as red and blue markings. The LIF gene is marked as the red 
box. The three treatment conditions sequence reads are contained in the rows marked ‘Proliferative’, 
‘Quiescent’, and ‘Rapamycin-treated’. Hollow red boxes have been placed over potential eRNA reads 
captured by RNA-sequencing in Rapamycin-treated samples. 
 
 
5.1  LIF interacts with high frequency with two nearby putative enhancers 
  LIF provided an ideal candidate to search for a nearby enhancer as it is highly up-regulated 
during treatment with Rapamycin and featured nearby eRNA transcripts in our RNA-Seq data. I 
hypothesized that the Rapamycin mediated up-regulation was due to an interaction forming between 
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LIF and an appropriate enhancer. Using 3C, we discovered that three sites in the LIF locus displayed high 
interaction frequency compared to the rest of the locus (Figure 5-2). These sites occurred at 43,400 bp 
upstream and at 5,800 bp and 7,900 bp downstream of the gene. The downstream site 5,800 bp away 
decreases interaction frequency in both quiescent (0.10-fold, relative to proliferative) and Rapamycin-
treated cells (0.12-fold, relative to proliferative) (Pro: 133 AU, Qui: 12.8 AU, Rap: 16.2 AU compared to 
background). Likewise, the downstream site 7,900 bp decreases interaction frequency in both quiescent 
(0.49-fold, relative to proliferative) and Rapamycin-treated cells (0.59-fold, relative to proliferative) (Pro: 
133 AU, Qui: 12.8 AU, Rap: 16.2 AU). For the interaction between LIF and a site 43,400 bp upstream, the 
highest interaction was detected in proliferative cells, a weaker interaction frequency in Rapamycin-
treated cells (0.67-fold, relative to proliferative), and a lower interaction frequency in quiescent cells 
(0.45-fold, relative to proliferative) (Pro: 246 AU, Qui: 110 AU, Rap: 164 AU compared to background). 
 
Figure 5-2: 3C profile of the LIF locus on chromosome 22 with LIF. (A) Screen-capture of UCSC Genome 
Browser featuring the H3K27Ac profile of all available cell types that was used when designing primers 
against putative enhancers. (B) Graphed 3C profile of interactions occurring between the LIF gene and 
several downstream and upstream putative enhancer sites. Interaction Frequency is measured by fold 
change comparison of detected products that have been normalized to a control interaction against 
background. Genomic distance is measured as the distance of the tested site versus the position of the 
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anchor (at the intercept or the vertical axis). Pro = proliferative (10% FBS), Qui = quiescence (0.5% FBS), 
Rap = Rapamycin Treated (500 nM). (* = P < 0.10, ** = P < 0.05, Student’s two-tailed t-test). (n = 5 for 
each treatment). 
 
 
Table 5-1: LIF anchored 3C investigations of chromosome 17 relative to proliferative samples. Table 
depicting interaction frequency relative to proliferative samples for examined 3C interactions on 
chromosome 22, between the Leukemia inhibitory factor (LIF) gene and several upstream (US) or 
downstream (DS) putative enhancer sites. Interactions are defined by a pair of primers with one primer 
chosen as a constant or ‘anchor’ primer for the assays and another as a variable primer. Distance is 
measured from the site of the anchor primer to the site of the variable primer. Negative distances 
indicate the variable primer is upstream of the anchor primer. Positive distances indicate the variable 
primer is downstream of the anchor primer. Fold change is calculated as a ratio of interaction frequency 
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compared to proliferative samples using the same primer pair. (** = P < 0.05, * = P < 0.10. Student’s 2-
tailed T-test). 
 
5.2 KRTAP2-3 anchored investigations of the KRTAP locus on chromosome 17. 
  We identified a cluster of keratin associated proteins (KRTAP) on chromosome 17, region 41 
Mbp that was differentially regulated in response to quiescence-induction and Rapamycin-treatment, 
and; therefore, a candidate region for investigating sub-chromosomal re-organization in response to 
gene regulation. In response to Rapamycin treatment many of these genes are up-regulated (KRTAP3-1, 
KRTAP4-7, KRTAP4-11, KRTAP4-12, KRTAP4-6, KRTAP4-5, KRTAP4-4), and during quiescence many of 
these genes are down-regulated (KRTAP1-5, KRTAP1-1, KRTAP2-3, KRTAP2-4, KRTAP4-12). Similar to our 
investigation of the cluster of chemokine genes on chromosome 4, we investigated if these genes were 
coming together for transcription during gene up-regulation, and further if they were disassociating 
during down-regulation. KRTAP2-3 was selected as the anchor, which is down-regulated during 
quiescence. 
  Our 3C analysis (Figure 5-3) revealed that KRTAP2-3 maintains several high frequency 
interactions with upstream genes of the KRTAP cluster on chromosome 17, as well as several weaker 
interactions with downstream genes. KRTAP2-3 displayed a high interaction frequency with KRTAP3-1 
(50,100 bp away) in proliferative cells; however, this interaction frequency significantly declined (P < 
0.10, student’s two-tailed t-test) for both quiescent (0.20-fold, relative to proliferative) and Rapamycin-
treated cells (0.19-fold, relative to proliferative) (Pro: 2786 AU, Qui: 558 AU, Rap: 542 AU compared to 
background). KRTAP2-3 also displayed high interaction frequency with KRTAP1-5 (39,500 bp away) in 
proliferative cells, and again displayed decreased interaction frequency for both quiescence (0.30-fold, 
relative to proliferative) and Rapamycin treated cells (0.29, relative to proliferative) (Pro: 2281 AU, Qui: 
681 AU, Rap: 661 AU, compared to background). KRTAP2-3 and KRTAP1-1 (27,100 bp apart) displayed 
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the highest interaction frequency in Rapamycin-treated cells, weaker for proliferative, and the lowest 
for quiescence cells (Pro: 3761 AU, Qui: 2906 AU, Rap: 4535 AU compared to background). Upstream of 
KRTAP2-3, interaction frequencies were detected for several genes. KRTAP2-3 displayed a unique 
interaction with KRTAP2-4 (6,500 bp away) only in quiescent and Rapamycin-treated cells (Pro: 1 AU, 
Qui: 403 AU, Rap: 418 AU compared to background). KRTAP2-3 also displayed detectable interactions 
with the distal KRTAP4-5 (87,800 bp away) with the highest interaction frequency in proliferative cells 
and lower interaction frequencies in quiescence (0.29-fold, relative to proliferative) and Rapamycin-
treated cells (0.41-fold, relative to proliferative) (Pro: 272 AU, Qui: 80.0 AU, Rap: 112 AU compared to 
background). KRTAP2-3 interacted with KRTAP4-4 (97,200 bp away) with the highest interaction 
frequency again in proliferative cells and lower interaction frequencies during quiescence (0.20-fold, 
relative to proliferative) and Rapamycin-treatment (0.16-fold, relative to proliferative) (Pro: 329 AU, Qui: 
66.1 AU, Rap: 53.0 AU, compared to background).  
 
91 
 
Figure 5-3: 3C profile of the KRTAP locus on chromosome 17 with KRTAP2-3 as the anchor fragment.  
(A) Graphed 3C profile of interactions occurring between the KRTAP2-3 (green box above graph) gene 
and several other KRTAP genes (blue boxes above graph). Interaction Frequency is measured by fold 
comparison of detected products that have been normalized to a control interaction against 
background. Genomic distance is measured as the distance of the tested site versus the position of the 
anchor (at ‘0’ or the vertical axis). (B) Relative expression of several KRTAP genes during three different 
treatment conditions as determined by RNA-Sequencing data (Gillespie et al, 2015) (GEO Accession: 
GSE65145). Y-axis indicates fold change in gene expression compared to proliferative values. Pro = 
proliferative (10% FBS), Qui = quiescence (0.5% FBS), Rap = Rapamycin Treated (500 nM). (* = P < 0.10, 
** = P < 0.05, Student’s two-tailed t-test). (n = 5 for each treatment). 
 
Table 5-2: KRTAP2-3 anchored 3C investigations of chromosome 17 relative to proliferative samples. 
Table depicting interaction frequency relative to proliferative samples for examined 3C interactions on 
chromosome 17 between keratin associated protein (KRTAP) genes. Interactions are defined by a pair of 
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primers with one primer chosen as a constant or ‘anchor’ primer for the assays and another as a variable 
primer. Distance is measured from the site of the anchor primer to the site of the variable primer. 
Negative distances indicate the variable primer is upstream of the anchor primer. Positive distances 
indicate the variable primer is downstream of the anchor primer. Fold change is calculated as a ratio of 
interaction frequency compared to proliferative samples using the same primer pair. (** = P < 0.05, * = P 
< 0.10. Student’s 2-tailed T-test). 
 
 
5.3 KRTAP4-5 anchored investigations of the KRTAP locus on chromosome 17 
  We chose a second anchor to further investigate the KRTAP locus on chromosome 17, region 41 
Mbp. KRTAP4-5 was selected as an anchor due to its up-regulation during Rapamycin treatment (Figure 
5-4, Table 5-3). By using a second anchor, we allow the identification of anchor bias and a 
characterization of interactions from a different viewpoint that will further instruct on local interactions. 
KRTAP4-5 displayed high interaction frequencies with KRTAP3-1 (137,900 bp away) with the highest 
frequency occurring in proliferative cells, weaker frequency in Rapamycin-treated cells (0.26-fold, 
relative to proliferative), and the lowest interaction frequency in quiescent cells (0.26-fold, relative to 
proliferative) (Pro: 647 AU, Qui: 268 AU, Rap: 166 AU, compared to background). KRTAP4-5 displayed 
the highest interaction frequencies with KRTAP1-1 (115,000 bp away). KRTAP4-5 to KRTAP1-1 
interaction frequency was highest in proliferative, lower in quiescent cells (0.73-fold, relative to 
proliferative), and the lowest in Rapamycin-treated cells (0.56-fold, relative to proliferative) (Pro: 1719 
AU, Qui: 1560 AU, Rap: 956 AU compared to background). KRTAP4-5 also displayed interaction 
frequencies with KRTAP2-3 (87,800 bp) (discussed previously) and KRTAP4-4 (8,200 bp away) (Pro: 144 
AU, Qui: 129 AU, Rap: 88.4 AU compared to background). 
   
93 
 
 
Figure 5-4: 3C profile of the KRTAP locus on chromosome 17 with KRTAP4-5 as the anchor fragment. 
(A) Graphed 3C profile of interactions occurring between the KRTAP4-5 (green box above graph) gene 
and several other KRTAP genes (blue boxes above graph). Interaction Frequency is measured by fold 
comparison of detected products that have been normalized to a control interaction against 
background. Genomic distance is measured as the distance of the tested site versus the position of the 
anchor (at ‘0’ or the vertical axis). (B) Relative expression of several KRTAP genes during three different 
treatment conditions as determined by RNA-Seq (Gillespie et al, 2015) (GEO Accession: GSE65145).  
Height of bars indicates fold change in gene expression compared to proliferative values. Pro = 
proliferative (10% FBS), Qui = quiescence (0.5% FBS), Rap = Rapamycin Treated (500 nM).  
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Table 5-3: KRTAP4-5 anchored 3C investigations of chromosome 17 relative to proliferative samples. 
Table depicting interaction frequency relative to proliferative samples for examined 3C interactions on 
chromosome 17 between keratin associated protein (KRTAP) genes. Interactions are defined by a pair of 
primers with one primer chosen as a constant or ‘anchor’ primer for the assays and another as a variable 
primer. Distance is measured from the site of the anchor primer to the site of the variable primer. 
Negative distances indicate the variable primer is upstream of the anchor primer. Positive distances 
indicate the variable primer is downstream of the anchor primer. Fold change is calculated as a ratio of 
interaction frequency compared to proliferative samples using the same primer pair.  
 
5.4 Discussion 
  In our analysis of gene architecture near the LIF gene, during quiescence we identified an 
expected decrease in interaction frequency with nearby sites compared to proliferative. However, we 
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also observed an unexpected decrease in interaction frequency during Rapamycin treatment when the 
gene is up-regulated 86-fold and expected to increase interaction frequency with these putative 
enhancers. While the explanation for this decrease in interaction frequency between LIF and nearby 
putative enhancers during Rapamycin treatment is unexpected, it is possible that these interactions are 
occurring at lower frequency due to the formation of new, as-of-yet unidentified interactions. For 
practicality, we only searched a limited distance upstream and downstream of the LIF gene for a 
possible enhancer. Certainly, more work must be performed on the region to characterize the functional 
implications of these changes, such as characterizing its relationship with other putative enhancers 
(H3K27Ac marks) in the region and discovering the protein factors responsible for mediating looping 
between LIF and regulatory elements. One relationship that can be drawn from this investigation is that 
during decreased nutrient available and growth signaling (quiescence) and perceived decreased nutrient 
availability (through inhibition of mTORC1 by Rapamycin), interaction frequency between LIF and these 
targeted putative enhancer sites decrease compared to proliferative cells. 
  In the KRTAP locus on chromosome 17, we discovered that proliferative samples displayed the 
highest interaction frequencies despite Rapamycin-treated samples having the highest expression of the 
contained KRTAP genes. Interestingly, we discovered similar interaction profiles when comparing 
quiescent and Rapamycin-treated samples, despite the opposite levels of transcription of the contained 
genes. Some portions of the KRTAP locus produced no interactions with either anchor despite up-
regulation of genes during Rapamycin treatment (KRTAP4-7, KRTAP4-11, KRTAP4-12, KRTAP4-6, KRTAP4-
4). This could be due to several reasons, namely that either interactions are not occurring between our 
anchors (KRTAP2-3, KRTAP4-5) and those genes, or that the difficult nature of primer design for the 
region precluded successful investigation of interactions. Upon further examination of this region using 
Hi-C, these concerns of primer design would be alleviated by a sequencing-based approach rather than a 
PCR-based method. 
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  Similar to results with the LIF locus, interaction frequencies of the KRTAP locus tended to 
decrease for both quiescent and Rapamycin-treated samples compared to proliferative samples. As 
mentioned previously, this decrease of interaction frequency may be the result of decreased nutrient 
and growth signals or the perceived decrease in nutrients due to mTORC1 inhibition. This is not 
unreasonable when considering that resources would be either limited, or perceived as limited, for the 
cell to accomplish normal function, and may result in decreasing interaction frequency to accommodate 
energy contexts. However, this fails to explain why several genes are still capable of considerable up-
regulation during treatment with Rapamycin, when actual energy is available, though downstream 
signaling of mTORC1 is inhibited.  
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6.0 Conclusions 
  Our experiments sought to elaborate the relationship between growth conditions and nutrient 
sensing to alterations in genome organization, focusing on genes up-regulated by treatment with 500 
nM Rapamycin. By comparing genome organization between three different growth conditions; 
proliferative, quiescence induction (serum reduction), and Rapamycin-treatment (500 nM), we sought to 
understand if reorganization of the genome would occur at the level of chromosome territories as well 
as at the sub-chromosomal level. 
  Our analysis of chromosome territory positioning by FISH, in response to our three conditions, 
yielded insights into the complicated relationship between genome organization and gene expression in 
response. To our surprise, and despite significant changes of the gene expression profile induced by 
quiescence induction (0.5% FBS) and Rapamycin-treatment (500 nM), we observed only minimal 
changes in the positioning of chromosome 4 which contained many genes with altered regulation. As 
expected with previous results, we recapitulated earlier observations that chromosome 18 and 10 
reposition in response to treatment with Rapamycin and induction into quiescence by serum starvation.  
  During our analysis of sub-chromosomal organization using 3C against the CXCL genes of 
interest, we discovered unique interactions when comparing cells under proliferative status versus 
quiescent induction or Rapamycin treatment. Previously, quiescence and Rapamycin treatment were 
thought to parallel each other, as they both adopted a flattened cellular morphology with decreased 
cellular proliferation during treatment. Work performed previously was the first to demonstrate these 
two treatments, though appearing similar at first, are quite distinct. The findings presented in this thesis 
agree with these earlier findings and further elaborate on the subtle organizational changes that occur 
concomitant with changes to gene expression. Significantly, our investigation of the CXCL locus on 
chromosome 4, region 74 Mbp, revealed a complex relationship between transcription and interaction 
frequency of the contained genes. For example, despite CXCL8 and CXCL2 being down-regulated during 
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quiescence, CXCL8 and CXCL2 displayed an increased interaction frequency compared to other 
treatments. Also interesting, both quiescence-induced and Rapamycin-treated cells displayed increased 
interaction frequency between CXCL8 and a site occurring 25,000 base pairs downstream of the gene, 
despite opposite levels of regulation for the gene (Pro: 1-fold, Qui: 4.12-fold, Rap: 5.96-fold, relative to 
the proliferative state). We also observed that many genes maintained interactions during altered gene 
expression, such as between CXCL8 and CXCL1, however proliferative and Rapamycin-treated cells often 
displayed the highest interaction frequency between genes – to some degree supporting the notion that 
increased transcription correlates with increased interaction frequency.  
  Outside of chromosome 4 we also investigated two cases of interest: the LIF gene on 
chromosome 22 and another cluster of genes (KRTAP) contained on chromosome 17, region 41 Mbp. 
Analysis of the LIF locus, in search for its enhancer(s), revealed high frequency interactions occurring 
between the gene and three nearby sites. These sites, occurring at ~5000 and ~8000 base pairs 
downstream and ~40,000 base pairs upstream of the gene, were both observed with the highest 
interaction frequency in proliferative cells, and at high frequency in both quiescent and Rapamycin-
treated cells. Interestingly, quiescent cells also displayed an increased interaction frequency with a site 
~35,000 bp downstream of the LIF gene. These results are complicated by the observation of lower 
interaction frequency between LIF and these putative enhancers during Rapamycin-treatment as 
compared to proliferative cells. As anticipated, if these sites are enhancers of the LIF gene, an increase in 
interaction frequency would be observed. Alternately, it is possible that these sites are alternate 
enhancers to a more effective enhancer, or that during up-regulation these interactions are weakened 
to favor another interaction. Currently the exact effect of these interactions are unclear, however they 
were observed occurring in all three conditions and most highly in proliferative cells. 
  During our analysis of the KRTAP locus on chromosome 17, containing eleven KRTAP genes, we 
discovered differential organization of the region when comparing among treatment conditions. 
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Proliferative cells again represented the highest frequency of interactions, as seen in the interactions 
occurring between KRTAP2-3 and KRTAP1-1, KRTAP2-3 and KRTAP1-5, and KRTAP2-3 and KRTAP3-1. The 
interactions between KRTAP2-3 and KRTAP1-5, or KRTAP2-3 and KRTAP3-1, were observed occurring at 
lower frequencies during quiescence and Rapamycin-treatment. When analyzing the region from a 
different viewpoint, KRTAP4-5, we observed a high interaction frequency between KRTAP4-5 and 
KRTAP1-1 at nearly 110,000 base pairs away, as well as an interaction occurring between KRTAP4-5 and 
KRTAP3-1 at nearly 140,000 base pairs away. Again, we observed the highest interaction frequency 
occurring in proliferative cells compared to the other two treatments. This is interesting due to 
Rapamycin-treated cells and quiescent cells having opposite levels of expression for many of these 
genes, but similarly decreased interaction frequency profiles for the KRTAP locus. 
   These findings indicate a complexity connecting genome organization and gene 
expression, in response to our proliferative, quiescent, and Rapamycin-treated conditions. Several 
possibilities exist to explain the trends observed in the presented data.  
  Firstly, it is unclear if the organization of the CXCL locus and KRTAP locus is centered on a 
transcription factory. During all three growth conditions, we observed interactions occurring between 
many of the CXCL genes, with some changes occurring during quiescent treatment. The KRTAP locus did 
display increased interaction frequency between KRTAP2-3 and KRTAP3-1 in proliferative cells, however 
transcription of the KRTAP genes was highest during treatment with rapamycin. Overall, the anticipated 
relationship between increased transcription during Rapamycin treatment, and increased interaction 
between the genes inside our loci of interest (CXCL and KRTAP loci), was not observed.  
  Secondly, as none of the genes (CXCL, KRTAP, or LIF) are ever completely silenced, it is possible 
that even low levels of transcription result in a transcriptionally permissive arrangement of the regions. 
Possibly, the regions are poised for transcription and interactions are maintained while awaiting 
transcriptional activation. 
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  Lastly, it seems possible that higher access to nutrients and other cellular resources may 
facilitate increased interaction frequency. In general, proliferative cells often displayed the highest 
interaction frequency between two sites, whereas quiescent and Rapamycin-treated cells displayed 
lower interaction frequencies. Quiescent and Rapamycin-treated cells both have reduced use of the 
mTORC1 signalling pathway, due to either less nutrients/resources available or inhibition of the pathway 
by Rapamycin. This may result in a more specialized interactions forming, compared to the proliferative 
state which may adopt a more elastic or promiscuous state made possible by (perceived) higher 
resource availability and the wide-spread transcription promotion of many genes by the mTORC1 
pathway. 
  In summary, while we observed altered interactions in our treatments, a direct relationship 
between increased transcription and increased interaction, or decreased transcription and decreased 
interaction, was not clear. Possibly, there are interactions altering in response to our treatments which 
were not captured by our investigations. It does remain clear, with the repositioning of chromosome 10 
and 18, as well as our observed interaction changes, that the genome is reorganizing in response to 
these quiescence and Rapamycin treatment. 
  How these findings relate to the ageing process or genome organization as a whole are 
complicated. Caloric restriction and Rapamycin-treatment have been observed extending the health 
span of several model organisms (Bjedov et al., 2010; Ehninger et al., 2014; Harrison et al., 2009) and 
here we have shown that genome organization varies between our three treatment conditions 
(proliferative, quiescence, and Rapamycin-treated).  
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7.0 Future Direction 
 Future investigations stemming from this project would naturally involve the use of two high-
throughput techniques to characterize genome organization in healthy cells, aged cells, and cells being 
treated with Rapamycin to reverse ageing. Firstly, analysis of whole genome organization by Hi-C would 
allow the characterization of lost and gained interactions as a result of treatment with the putative anti-
ageing drug Rapamycin, and perhaps give insight into regulatory mechanisms beneficial to mitigating the 
aging process, and mechanisms that worsen or incur ageing. Secondly, use of ChIP-Seq to characterize 
histone marks (such as H3K27Ac, a mark of enhancers) or transcription factors of interest (such as 
STAT5A/B – potential activator of many of the up-regulated CXCL genes) could elaborate on the 
mechanisms facilitating genome organization and reorganization. In characterizing these realms 
thoroughly both the alterations to organization and the effectors or organization could be identified. By 
understanding the alterations acquired in the ageing process, and the mitigating changes induced by 
Rapamycin treatment or other drugs, ageing mechanisms can be characterized. This could then be 
expanded into understanding how nutrition and nutrient sensing affect health and life span and how 
this can be used practically. 
  Characterizing genome organization in the context of ageing is fundamental to the process of 
combating it. In cells of patients with HGPS, a malformed nucleus is observed caused by inappropriate 
function of the LMNA/C protein, with clear consequences on nuclear organization and organismal health 
such as reduced DNA repair. As the symptoms of HGPS are highly similar to the normal ageing process, 
albeit at a much faster rate (HGPS sufferers often only live into mid-teens), it is readily apparent that 
genome organization has links to ageing phenotypes. This disorganization is caused by the accumulation 
of an aberrant LMNA/C protein inside the nucleus. Hope for treatment of HGPS lies in inducing the 
increased recycling of these gradually accumulating proteins that may allow the nucleus to return to a 
healthy phenotype with appropriate organization.  Currently, investigations are underway in the Eskiw 
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laboratory to induce this recycling by restricting essential amino acids and inducing cells to recycle the 
aberrant and accumulated LMNA/C proteins.  
  Following the characterization of alterations to genome topology in response to Rapamycin 
treatment or dietary changes in normal healthy cells, a ‘healthy and young’ model of genome 
organization could be established. As cells age (and potentially devolve into a cancerous lineage), gene 
expression can alter inappropriately in response to genome changes, such as mutations, translations, 
deletions, or alterations to chromatin and epigenetics marks. In characterizing either young phenotype, 
or an anti-aging phenotype, and aged phenotypes, the alterations that occur in older and degrading cells 
may become readily apparent and emerge as targets to mitigate aging. By identifying and remediating 
these age-based alterations to the genome and genome topology, cellular health and age phenotype 
may be reversible to a normal status through the tailored use of drugs, diet, and gene editing in cellular 
models.  
  Once these anti-aging mechanisms are established in a cell model, they could be elevated for 
use in mice or another model organism. Whole organismal models provide significant boundaries 
compared to cellular models due to the complexity, variety, and accessibility to various tissues. A 
significant benefit of mediating ageing phenotypes through diet, is the effectiveness and tissue reach of 
nutrients. While drugs are limited by bioavailability, all cells require a certain upkeep of nutrients and 
actively ensure they can be provided for the cell. Nutrition provides a ‘highly penetrative’ approach to 
tackling ageing, since cells actively absorb nutrients. Diet can also be highly controlled by mediating 
ingestion of targeted amino acids, or other substances such as polyphenols. Perhaps by characterizing 
the genome topology changes of ageing, and understanding how nutrition and nutritional response 
drive topology changes, moderate and practical changes to diet can extend health and lifespan as well 
as combat other disease states.      
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